WO2000071201A1 - System promoting atrial pacing - Google Patents

System promoting atrial pacing Download PDF

Info

Publication number
WO2000071201A1
WO2000071201A1 PCT/US2000/013863 US0013863W WO0071201A1 WO 2000071201 A1 WO2000071201 A1 WO 2000071201A1 US 0013863 W US0013863 W US 0013863W WO 0071201 A1 WO0071201 A1 WO 0071201A1
Authority
WO
WIPO (PCT)
Prior art keywords
interval
atrial
indicated
indicated pacing
rate
Prior art date
Application number
PCT/US2000/013863
Other languages
French (fr)
Inventor
Jesse W. Hartley
Andrew P. Kramer
Jeffrey E. Stahmann
David B. Krig
Original Assignee
Cardiac Pacemakers, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/316,682 priority Critical patent/US6351669B1/en
Priority claimed from US09/316,515 external-priority patent/US7062325B1/en
Priority claimed from US09/316,741 external-priority patent/US6430438B1/en
Priority claimed from US09/316,588 external-priority patent/US6285907B1/en
Application filed by Cardiac Pacemakers, Inc. filed Critical Cardiac Pacemakers, Inc.
Priority to AU51469/00A priority patent/AU5146900A/en
Priority to PCT/US2000/013863 priority patent/WO2000071201A1/en
Priority to US09/693,402 priority patent/US6353759B1/en
Publication of WO2000071201A1 publication Critical patent/WO2000071201A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/3621Heart stimulators for treating or preventing abnormally high heart rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3956Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
    • A61N1/3962Implantable devices for applying electric shocks to the heart, e.g. for cardioversion in combination with another heart therapy
    • A61N1/39622Pacing therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/3627Heart stimulators for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/365Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/368Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
    • A61N1/3682Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions with a variable atrioventricular delay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/395Heart defibrillators for treating atrial fibrillation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3987Heart defibrillators characterised by the timing or triggering of the shock

Definitions

  • This invention relates generally to cardiac rhythm management systems and particularly, but not by way of limitation, to a cardiac rhythm management system promoting atrial pacing.
  • cardiac arrhythmias When functioning properly, the human heart maintains its own intrinsic rhythm, and is capable of pumping adequate blood throughout the body's circulatory system. However, some people have irregular cardiac rhythms, referred to as cardiac arrhythmias. Such arrhythmias result in diminished blood circulation.
  • One mode of treating cardiac arrhythmias uses drug therapy. Drug therapy is not always effective for treating arrhythmias of certain patients. For such patients, an alternative mode of treatment is needed.
  • One such alternative mode of treatment includes the use of a cardiac rhythm management system. Such systems are often implanted in the patient and deliver therapy to the heart. Cardiac rhythm management systems include, among other things, pacemakers, also referred to as pacers.
  • Pacers deliver timed sequences of low energy electrical stimuli, called pace pulses, to the heart, such as via a transvenous leadwire or catheter (referred to as a "lead") having one or more electrodes disposed in or about the heart. Heart contractions are initiated in response to such pace pulses (this is referred to as "capturing" the heart). By properly timing the delivery of pace pulses, the heart can be induced to contract in proper rhythm, greatly improving its efficiency as a pump. Pacers are often used to treat patients with bradyarrhythmias, that is, hearts that beat too slowly, or irregularly. Cardiac rhythm management systems also include cardioverters or defibrillators that are capable of delivering higher energy electrical stimuli to the heart.
  • a defibrillator is capable of delivering an high energy electrical stimulus that is sometimes referred to as a defibrillation shock. The shock interrupts the tachyarrhythmia, allowing the heart to reestablish a normal rhythm for the efficient pumping of blood.
  • cardiac rhythm management systems also include, among other things, pacer/defibrillators that combine the functions of pacers and defibrillators, drug delivery devices, and any other systems or devices for diagnosing or treating cardiac arrhythmias.
  • Atrial fibrillation is a common cardiac arrhythmia which reduces the pumping efficiency of the heart, though not to as great a degree as in ventricular fibrillation.
  • this reduced pumping efficiency requires the ventricle to work harder, which is particularly undesirable in sick patients that cannot tolerate additional stresses.
  • atrial fibrillation patients must typically limit their activity and exercise.
  • Atrial fibrillation by itself, is usually not life-threatening, prolonged atrial fibrillation may be associated with strokes, which are thought to be caused by blood clots forming in areas of stagnant blood flow. Treating such blood clots requires the use of anticoagulants. Atrial fibrillation may also cause pain, dizziness, and other irritation to the patient. For this reason, atrial fibrillation is typically treated with a low energy defibrillation shock to enable the resumption of normal atrial heart rhythms. An even more serious problem, however, is the risk that atrial fibrillation may induce irregular ventricular heart rhythms by processes that are yet to be fully understood.
  • Atrial fibrillation by a defibrillation shock may also induce dangerous ventricular arrhythmias.
  • atrial tachyarrhythmias such as atrial fibrillation
  • a cardiac rhythm management system including an atrial pacing preference (APP) filter for promoting atrial pacing.
  • the APP filter controls the timing of delivery of atrial pacing pulses.
  • the atrial pacing pulses are delivered at a first indicated pacing rate, i.e., the APP-indicated rate, that is typically at a small amount above the intrinsic atrial heart rate.
  • the APP-indicated rate is increased until it becomes slightly faster than the intrinsic atrial heart rate of the sensed atrial beat.
  • the APP-indicated pacing rate is then gradually decreased to search for the underlying intrinsic atrial heart rate.
  • the APP filter again elevates the APP-indicated pacing rate until it is above the intrinsic heart atrial rate by a small amount.
  • the APP filter again elevates the APP-indicated pacing rate until it is above the intrinsic heart atrial rate by a small amount.
  • most atrial heart beats are paced, rather than sensed.
  • This is believed to decrease the likelihood of the occurrence of an atrial tachyarrhythmia, such as atrial fibrillation.
  • the decreased likelihood of atrial tachyarrhythmia decreases the likelihood of inducing a ventricular arrhythmia, either as a result of the atrial tachyarrhythmia, or as the result of delivering a defibrillation shock to treat the atrial tachyarrhythmia.
  • the cardiac rhythm management system includes a method comprising: (1) obtaining A- A intervals between atrial beats, (2) computing a first indicated pacing interval based at least on a most recent A-A interval duration and a previous value of the first indicated pacing interval, and (3) providing atrial pacing therapy, based on the first indicated pacing interval.
  • the cardiac rhythm management system includes an atrial sensing circuit, an atrial therapy circuit, and a controller.
  • the controller includes an A-A interval timer, a first register, for storing a first indicated pacing interval, and a filter, updating the first indicated pacing interval based on the A- A interval timer and the first register.
  • the atrial therapy circuit provides pacing therapy based at least partially on the first indicated pacing interval.
  • FIG. 1 is a schematic drawing illustrating one embodiment of portions of a cardiac rhythm management system and an environment in which it is used.
  • Figure 2 is a schematic drawing illustrating one embodiment of a cardiac rhythm management device coupled by leads to portions of a heart.
  • Figure 3 is a schematic diagram illustrating generally one embodiment of portions of a cardiac rhythm management device which is coupled to a heart.
  • Figure 4 is a schematic diagram illustrating generally one embodiment of a controller that includes several different inputs to modify the rate at which pacing or other therapy is delivered.
  • Figure 5 is a schematic diagram illustrating generally one conceptualization of portions of a controller.
  • Figure 6 is a signal flow diagram illustrating generally one embodiment of operating a filter.
  • Figure 7 is a signal flow diagram illustrating generally aspects of another conceptualization of operating the filter.
  • Figure 8 is a signal flow diagram illustrating generally aspects of a further conceptualization of operating the filter.
  • Figure 9 is a schematic diagram illustrating generally another conceptualization of portions of a controller.
  • Figure 10 is a graph illustrating generally one embodiment of operating a filter to provide a first indicated rate, such as an Atrial Pacing Preference ("APP") indicated rate, for successive atrial heart beats.
  • APP Atrial Pacing Preference
  • Figure 11 is a graph illustrating generally another embodiment of operating a filter to provide a first indicated pacing rate, such as an APP indicated rate, and delivering therapy based on the first indicated pacing rate and based on a second indicated pacing rate, such as a sensor indicated rate.
  • a first indicated pacing rate such as an APP indicated rate
  • Figure 12 is a graph illustrating generally one embodiment of using at least one of coefficients a and b as a function of heart rate (or a conesponding time interval).
  • a cardiac rhythm management system including an atrial pacing preference (APP) filter for promoting atrial pacing over atrial sensing.
  • the APP filter controls the timing of delivery of atrial pacing pulses.
  • the atrial pacing pulses are delivered at a first indicated pacing rate, i.e., the APP-indicated pacing rate, that is typically at a small amount above the intrinsic atrial heart rate.
  • the APP-indicated rate is slowly decreased to search for the underlying intrinsic atrial heart rate. Then, after a sensed atrial beat, the APP filter increases the pacing rate until it becomes faster than the intrinsic atrial rate by a small amount.
  • Atrial tachyarrhythmia such as atrial fibrillation.
  • the decreased likelihood of atrial tachyanhythmia decreases the likelihood of inducing a ventricular arrhythmia, either as a result of the atrial tachyarrhythmia, or as the result of delivering a defibrillation shock to treat the atrial tachyanhythmia.
  • FIG. 1 is a schematic drawing illustrating, by way of example, but not by way of limitation, one embodiment of portions of a cardiac rhythm management system 100 and an environment in which it is used.
  • system 100 includes an implantable cardiac rhythm management device 105, also refened to as an electronics unit, which is coupled by an intravascular endocardial lead 110, or other lead, to a heart 115 of patient 120.
  • System 100 also includes an external programmer 125 providing wireless communication with device 105 using a telemetry device 130.
  • Catheter lead 110 includes a proximal end 135, which is coupled to device 105, and a distal end 140, which is coupled to one or more portions of heart 115.
  • FIG. 2 is a schematic drawing illustrating, by way of example, but not by way of limitation, one embodiment of device 105 coupled by one or more leads, such as leads 110A-B, to heart 115, which includes a right atrium 200 A, a left atrium 200B, a right ventricle 205A, a left ventricle 205B, and a coronary sinus 220 extending from right atrium 200A.
  • atrial lead 110A includes electrodes (electrical contacts) disposed in, around, or near right atrium 200A of heart 115, such as ring electrode 225 and tip electrode 230, for sensing signals and or delivering pacing therapy to the right atrium 200A.
  • Lead 110A optionally also includes additional electrodes, such as for delivering atrial and/or ventricular cardioversion/defibrillation and/or pacing therapy to heart 115.
  • a ventricular lead HOB includes one or more electrodes, such as tip electrode 235 and ring electrode 240, for sensing signals and/or delivering pacing therapy.
  • Lead HOB optionally also includes additional electrodes, such as for delivering atrial and/or ventricular cardioversion/defibrillation and/or pacing therapy to heart 115.
  • Device 105 includes components that are enclosed in a hermetically-sealed can 250. Additional electrodes may be located on the can 250, or on an insulating header 255, or on other portions of device 105, for providing unipolar pacing and/or defibrillation energy in conjunction with the electrodes disposed on or around heart 115.
  • Electrodes include meshes and patches which may be applied to portions of heart 115 or which may be implanted in other areas of the body to help "steer” electrical cunents produced by device 105.
  • the present method and apparatus will work in a variety of configurations and with a variety of electrical contacts or "electrodes.”
  • Example Cardiac Rhythm Management Device Figure 3 is a schematic diagram illustrating generally, by way of example, but not by way of limitation, one embodiment of portions of device 105, which is coupled to heart 115.
  • Device 105 includes a power source 300, an atrial sensing circuit 305, an atrial therapy circuit 310, and a controller 325.
  • Device 105 also optionally includes a ventricular sensing circuit 315 and a ventricular therapy circuit 320.
  • Atrial sensing circuit 305 is coupled by atrial lead 110A to heart 115 for receiving, sensing, and/or detecting electrical atrial heart signals.
  • Such atrial heart signals include atrial activations (also refened to as atrial depolarizations or P-waves), which conespond to atrial contractions.
  • Such atrial heart signals include normal atrial rhythms, and abnormal atrial rhythms including atrial tachyanhythmias, such as atrial fibrillation, and other atrial activity.
  • Atrial sensing circuit 305 provides one or more signals to controller 325, via node/bus 327, based on the received atrial heart signals. Such signals provided to controller 325 indicate, among other things, the presence of sensed intrinsic atrial heart contractions.
  • Atrial therapy circuit 310 provides atrial pacing therapy, as appropriate, to electrodes located at or near one of the atria 200 of heart 115 for obtaining resulting evoked atrial depolarizations. In one embodiment, atrial therapy circuit 310 also provides cardioversion/defibrillation therapy, as appropriate, to electrodes located at or near one of the atria 200 of heart 115, for terminating atrial fibrillation and or other atrial tachyanhythmias.
  • Ventricular sensing circuit 315 is coupled by ventricular lead HOB to heart 115 for receiving, sensing, and/or detecting electrical ventricular heart signals, such as ventricular activations (also refened to as ventricular depolarizations or R-waves), which conespond to ventricular contractions.
  • electrical ventricular heart signals such as ventricular activations (also refened to as ventricular depolarizations or R-waves), which conespond to ventricular contractions.
  • ventricular heart signals include normal ventricular rhythms, and abnormal ventricular rhythms, including ventricular tachyanhythmias, such as ventricular fibrillation, and other ventricular activity, such as inegular ventricular contractions resulting from conducted signals from atrial fibrillation.
  • Ventricular sensing circuit 315 provides one or more signals to controller 325, via node/bus 327, based on the received ventricular heart signals.
  • signals provided to controller 325 indicate, among other things, the presence of ventricular depolarizations, whether regular or inegular in
  • Ventricular therapy circuit 320 provides ventricular pacing therapy, as appropriate, to electrodes located at or near one of the ventricles 205 of heart 115 for obtaining resulting evoked ventricular depolarizations. In one embodiment, ventricular therapy circuit 320 also provides cardioversion/defibrillation therapy, as appropriate, to electrodes located at or near one of the ventricles 205 of heart 115, for terminating ventricular fibrillation and/or other ventricular tachyanhythmias .
  • Controller 325 controls the delivery of therapy by atrial therapy circuit 310, ventricular therapy circuit 320, and/or other circuits, based on heart activity signals received from atrial sensing circuit 305 and ventricular sensing circuit 315, as discussed below.
  • Controller 325 includes various modules, which are implemented either in hardware or as one or more sequences of steps carried out on a microprocessor or other controller. Such modules are illustrated separately for conceptual clarity; it is understood that the various modules of controller 325 need not be separately embodied, but may be combined and or otherwise implemented, such as in software/firmware.
  • sensing circuits 305 and 310 sense electrical signals from heart tissue in contact with the catheter leads 110A-B to which these sensing circuits 305 and 310 are coupled. Sensing circuits 305 and 310 and/or controller 325 process these sensed signals. Based on these sensed signals, controller 325 issues control signals to therapy circuits, such as atrial therapy circuit 310 and/or ventricular therapy circuit 320, if necessary, for the delivery of electrical energy (e.g., pacing and/or defibrillation pulses) to the appropriate electrodes of leads 110A-B.
  • Controller 325 may include a microprocessor or other controller for execution of software and/or firmware instructions. The software of controller 325 may be modified (e.g., by remote external programmer 105) to provide different parameters, modes, and/or functions for the implantable device 105 or to adapt or improve performance of device 105.
  • one or more sensors may serve as inputs to controller 325 for adjusting the rate at which pacing or other therapy is delivered to heart 115.
  • One such sensor 330 includes an accelerometer that provides an input to controller 325 indicating increases and decreases in physical activity, for which controller 325 increases and decreases pacing rate, respectively.
  • Another such sensor includes an impedance measurement, obtained from body electrodes, which provides an indication of increases and decreases in the patient's respiration, for example, for which controller 325 increases and decreases pacing rate, respectively. Any other sensor 330 providing an indicated pacing rate can be used.
  • Figure 4 is a schematic diagram illustrating generally, by way of example, but not by way of limitation, one embodiment of controller 325 that includes several different inputs to modify the rate at which pacing or other therapy is delivered.
  • Input #1 may provide information about atrial heart rate
  • Input #2 may provide information about ventricular heart rate
  • Input #3 may provide an accelerometer-based indication of activity
  • Input #4 may provide an impedance-based indication of respiration, such as minute ventilation.
  • controller 325 Based on at least one of these and/or other inputs, controller 325 provides an output indication of pacing rate as a control signal delivered to a therapy circuit, such as to one or more of atrial therapy circuit 310 and ventricular therapy circuit 320.
  • Atrial therapy circuit 310 and ventricular therapy circuit 320 issue pacing pulses based on one or more such control signals received from controller 325.
  • Control of the pacing rate may be performed by controller 325, either alone or in combination with peripheral circuits or modules, using software, hardware, firmware, or any combination of the like.
  • the software embodiments provide flexibility in how inputs are processed and may also provide the opportunity to remotely upgrade the device software while still implanted in the patient without having to perform surgery to remove and/or replace the device 105.
  • Controller Example 1 Figure 5 is a schematic diagram illustrating generally, by way of example, but not by way of limitation, one conceptualization of portions of controller 325.
  • At least one signal from atrial sensing circuit 305 is received by atrial event module 500, which recognizes the occurrence of atrial events included within the signal. Such events are also refened to as “beats,” “activations,” “depolarizations,” “P-waves,” or “contractions. " Atrial event module 500 detects intrinsic events (also refened to as sensed events) from the signal obtained from atrial sensing circuit 305. Atrial event module 500 also detects evoked events (resulting from a pace) either from the signal obtained from atrial sensing circuit 305, or preferably from an atrial pacing control signal obtained from pacing control module 505, which also triggers the delivery of a pacing stimulus by atrial therapy circuit 310.
  • Atrial events include both intrinsic/sensed events and evoked/paced events.
  • a time interval between successive atrial events refened to as an A-A interval, is recorded by a first timer, such as A-A interval timer 510.
  • a filter 515 computes a "first indicated pacing interval," i.e., one indication of a desired time interval between atrial events or, stated differently, a desired atrial heart rate.
  • the first indicated pacing interval is also refened to as an atrial pacing preference (APP) indicated pacing interval.
  • APP atrial pacing preference
  • filter 515 includes an averager, a weighted averager, a median filter, an infinite impulse (IIR) filter, a finite impulse response (FIR) filter, or any other analog or digital signal processing circuit providing the desired signal processing described more particularly below.
  • filter 515 computes a new value of the first indicated pacing interval (also refened to as the APP-indicated pacing interval) based on the duration of the most recent A-A interval recorded by timer 510 and on a previous value of the first indicated pacing interval stored in first indicated pacing interval register 520.
  • Register 520 is then updated by storing the newly computed first indicated pacing interval in register 520.
  • pacing control module 505 Based on the first indicated pacing interval stored in register 520, pacing control module 505 delivers control signals to atrial therapy circuit 310 for delivering therapy, such as pacing stimuli, at the APP-indicated atrial heart rate conesponding to the inverse of the duration of the first indicated pacing interval.
  • therapy such as pacing stimuli
  • device 105 obtains A-A intervals between successive sensed or evoked atrial beats.
  • Device 105 computes a new first indicated pacing interval based at least in part on the duration of the most recent A-A interval and a previous value of the first indicated pacing interval.
  • Device 105 provides atrial pacing therapy delivered at a rate conesponding to the inverse of the duration of the first indicated pacing interval.
  • Figure 6 is a signal flow diagram illustrating generally, by way of example, but not by way of limitation, one embodiment of operating filter 515.
  • timer 510 Upon the occunence of a sensed or evoked atrial beat, timer 510 provides filter 515 with the duration of the A-A interval concluded by that beat, which is refened to as the most recent A-A interval (AA n ). Filter 515 also receives the previous value of the first indicated pacing interval (E réelle_ y ) stored in register 520. The most recent A-A interval AA n and the previous value of the first indicated pacing interval T n _, are each scaled by respective constants A and B, and then summed to obtain a new value of the first indicated pacing interval (T n ), which is stored in register 520 and provided to pacing control module 505. In one embodiment, the coefficients A and B are different values, and are either programmable, variable, or constant.
  • pacing control module 505 instructs atrial therapy circuit 310 to deliver an atrial pacing pulse upon the expiration of the new first indicated pacing interval T n .
  • Initialization of filter 515 includes seeding the filter by storing, in register
  • register 520 an initial interval value.
  • register 520 is initialized to an interval value conesponding to a lower rate limit (LRL), i.e., a minimum rate at which pacing pulses are delivered by device 105.
  • LLR lower rate limit
  • Register 520 could alternatively be initialized with any other suitable value.
  • operation of filter 515 is based on whether the beat concluding the most recent A-A interval AA n is a sensed/intrinsic beat or a paced/evoked beat.
  • the pacing control module 505 which controls the timing and delivery of pacing pulses, provides an input to filter 515 that indicates whether the most recent A-A interval AA n was concluded by an evoked beat initiated by a pacing stimulus delivered by device 105, or was concluded by an intrinsic beat sensed by atrial sensing circuit 305.
  • filter 515 provides a new first indicated pacing interval T n that is adjusted from the value of the previous first indicated pacing interval T n _, such as, for example, decreased by an amount that is based at least partially on the duration of the most recent A-A interval AA n and on the duration of the previous value of the first indicated pacing interval T n _,.
  • filter 515 provides a new first indicated pacing interval T fur that is increased from the value of the previous first indicated pacing interval _T Period_ 7 , such as, for example, by an amount that is based at least partially on the duration of the most recent A-A interval AA n and on the duration of the previous value of the first indicated pacing interval T n .
  • pacing control module 505 instructs atrial therapy circuit 310 to deliver an atrial pacing pulse upon the expiration of the new first indicated pacing interval T n .
  • FIG. 7 is a signal flow diagram, illustrating generally, by way of example, but not by way of limitation, another conceptualization of operating filter 515, with certain differences from Figure 6 more particularly described below.
  • the pacing control module 505 which controls the timing and delivery of pacing pulses, provides an input to filter 515 that indicates whether the most recent A-A interval AA n was concluded by an evoked beat initiated by a pacing stimulus delivered by device 105, or was concluded by an intrinsic beat sensed by atrial sensing circuit 305.
  • the most recent A-A interval AA n was concluded by an intrinsic beat, then the most recent A-A interval, AA n , and the previous value of the first indicated pacing interval, T n _, are each scaled by respective constants A and B, and then summed to obtain the new value of the first indicated pacing interval T n , which is stored in register 520 and provided to pacing control module 505.
  • the coefficients C and D are different from each other, and are either programmable, variable, or constant.
  • the coefficient C is a different value from the coefficient A, and or the coefficient D is a different value than the coefficient B, and these coefficients are either programmable, variable, or constant.
  • the coefficient D is the same value as the coefficient B.
  • pacing control module 505 instructs atrial therapy circuit 310 to deliver an atrial pacing pulse upon the expiration of the new first indicated pacing interval T n .
  • these coefficients can be more particularly described using an intrinsic coefficient (a), a paced coefficient (b), and a weighting coefficient (w).
  • A a-w
  • B (l-w)
  • C b-w
  • D (l-w).
  • pacing control module 505 instructs atrial therapy circuit 310 to deliver an atrial pacing pulse upon the expiration of the new first indicated pacing interval T n .
  • the coefficients a and b are different from each other, and are either programmable, variable, or constant.
  • weighting coefficient vv intrinsic coefficient a, arid paced coefficient b, are variables.
  • vv 1/32.
  • Other values of vv which need not include division by powers of two, may be substituted without departing from the present method and apparatus.
  • filter 515 provides a new first indicated pacing interval T ⁇ that is at least slightly shorter than the expected intrinsic A-A interval being measured by timer 515.
  • filter 515 operates to promote atrial pacing by increasing the APP-indicated rate until it becomes slightly faster than the intrinsic atrial rate.
  • the APP-indicated rate is then gradually decreased to search for the underlying intrinsic atrial heart rate.
  • the APP filter 515 again increases the APP indicated pacing rate until it becomes faster than the intrinsic atrial rate by a small amount. As a result, most atrial heart beats are paced, rather than sensed.
  • Atrial tachyanhythmia This decreases the likelihood of the occunence of an atrial tachyanhythmia, such as atrial fibrillation.
  • the decreased likelihood of atrial tachyanhythmia decreases the likelihood of inducing a ventricular anhythmia, either as a result of the atrial tachyanhythmia, or as the result of delivering a defibrillation shock to treat the atrial tachyanhythmia.
  • Controller Example 2 is a schematic diagram illustrating generally, by way of example, but not by way of limitation, another conceptualization of portions of controller 325, with certain differences from Figure 5 more particularly described below.
  • controller 325 receives from sensor 330 a signal including information from which a physiologically desired heart rate (e.g., based on the patient's activity, respiration, or any other suitable indicator of metabolic need) can be derived.
  • the sensor signal is digitized by an A/D converter 900.
  • the digitized signal is processed by a sensor rate module 905, which computes a desired heart rate that is expressed in terms of a second indicated pacing interval stored in register 910.
  • the second indicated pacing interval is also refened to as a sensor-indicated pacing interval, or if expressed in terms of rate, a sensor-indicated pacing rate.
  • Pacing control module 505 delivers a control signal, which directs atrial therapy circuit 310 to deliver a pacing pulse, based on either (or both) of the first or second indicated pacing intervals, stored in registers 520 and 910, respectively.
  • pacing control module 505 includes a selection module 915 that selects between the new first indicated pacing interval T n and the sensor-based second indicated pacing interval. In one embodiment, selection module 915 selects the shorter of the first and second indicated pacing intervals as the selected indicated pacing interval S ⁇ .
  • pacing control module 505 instructs atrial therapy circuit 320 to deliver an atrial pacing pulse upon the expiration of the selected indicated pacing interval S n .
  • the atrium is paced at the higher of the sensor indicated rate and the APP-indicated rate. If, for example, the patient is resting, such that the sensor indicated rate is lower than the patient's intrinsic rate, then atrial pacing pulses will be delivered at the APP-indicated rate, which is typically slightly higher than the patient's intrinsic atrial heart rate. But if, for example, the patient is active, such that the sensor indicated rate is higher than the APP-indicated rate, then pacing pulses generally will be delivered at the sensor indicated rate.
  • the pacing rate is determined by blending the sensor indicated rate and the APP-indicated rate, rather than by selecting the higher of these two indicated rates (i.e., the shorter of the first and second indicated pacing intervals).
  • selection module 915 applies predetermined or other weights to the first and second indicated pacing intervals to compute the selected pacing interval S faux.
  • FIG. 10 is a graph illustrating generally, by way of example, but not by way of limitation, one embodiment of an APP-indicated rate for successive atrial heart beats for one mode of operating filter 515.
  • the APP- indicated rate is simply the frequency, between atrial heart beats, associated with the first indicated pacing interval. Stated differently, the APP indicated rate is inversely related to the duration of the first indicated pacing interval. If pacing is based solely on the APP indicated rate, pacing control module 505 directs atrial therapy circuit 310 to issue a pacing pulse after the time since the last atrial beat equals or exceeds the first indicated pacing interval.
  • pacing control module 505 directs atrial therapy circuit 310 to issue a pacing pulse based on factors other than the APP indicated rate such as for, example, based on the sensor indicated rate.
  • a first paced atrial beat, indicated by a "P" was issued upon expiration of the first indicated pacing interval (i.e., the APP indicated pacing interval) T 0 , as computed based on a previous atrial beat.
  • the new APP indicated pacing interval T is computed based on the duration of most recent A-A interval AA, and a previous value of the APP indicated pacing interval T 0 , as discussed above.
  • the new APP indicated pacing interval T conesponds to a lower rate limit (LRL) time interval.
  • the allowable range of the APP indicated pacing interval is limited so that the APP indicated pacing interval does not exceed the duration of the LRL time interval, and so that the APP indicated pacing interval is not shorter than the duration of an upper rate limit (URL) time interval.
  • URL upper rate limit
  • the second atrial beat is also paced upon expiration of the APP indicated pacing interval T,.
  • the new APP indicated pacing interval T 2 is computed based on the duration of most recent A-A interval AA 2 and a previous value of the APP indicated pacing interval, T, as discussed above.
  • the first and second atrial beats are paced beats because the APP indicated atrial heart rate is higher than the underlying intrinsic atrial heart rate.
  • the third atrial beat is sensed well before expiration of the APP indicated pacing interval T 2 , such that no pacing pulse is issued.
  • filter 515 computes the new APP indicated pacing interval T 3 as being shorter in duration relative to the previous APP indicated pacing interval T 2 .
  • the fourth, fifth, and sixth atrial beats are sensed before expiration of the
  • filter 515 For each of the sensed fourth, fifth, and sixth atrial beats, filter 515 computes a new APP indicated pacing interval as being shorter in duration relative to the previous APP indicated pacing interval.
  • the APP indicated heart rate has increased above the underlying intrinsic atrial heart rate, such that the seventh atrial beat is paced upon expiration of the APP indicated pacing interval T 6 . Because the seventh atrial beat is paced, rather than sensed, the new APP indicated pacing interval T 7 is computed as being longer than the previous APP indicated pacing interval T 6 .
  • the eighth and ninth atrial beats are each paced upon expiration of the conesponding APP indicated pacing interval, i.e., T 7 , and T s , respectively.
  • Each APP indicated pacing interval T 7 , and T 8 is longer than the conesponding previous APP indicated pacing interval, i.e., T 6 , and T 7 , respectively.
  • the APP indicated atrial heart rate is gradually decreased to search for the underlying intrinsic atrial heart rate.
  • the APP indicated heart rate has been lowered sufficiently to allow the sensing of the tenth atrial beat.
  • the tenth atrial beat is sensed before expiration of the APP indicated pacing interval T 9 , such that no pacing pulse is issued.
  • filter 515 computes the new APP indicated pacing interval T 10 as being shorter in duration relative to the previous APP indicated pacing interval T 9 .
  • the eleventh atrial beat is paced upon expiration of the APP indicated pacing interval T 10 .
  • filter 515 For the paced eleventh atrial beat, filter 515 computes the new APP indicated pacing interval T u as being longer in duration relative to the previous APP indicated pacing interval T w .
  • the twelfth and thirteenth atrial beats are each paced upon expiration of the conesponding APP indicated pacing interval, i.e., T,demand and T 12 , respectively.
  • Each APP indicated pacing interval T 12 , and T 13 is longer than the conesponding previous APP indicated pacing interval, i.e., T u , and T 12 , respectively. In this way, the APP indicated atrial heart rate is gradually decreased to find the underlying intrinsic atrial heart rate.
  • the fourteenth atrial beat is sensed before expiration of the APP indicated pacing interval T 13 , such that no pacing pulse is issued.
  • filter 515 computes the new APP indicated pacing interval T l4 as being shorter in duration relative to the previous APP indicated pacing interval T I3 .
  • the fifteenth atrial beat is paced upon expiration of the APP indicated pacing interval T 14 .
  • filter 515 computes the new APP indicated pacing interval T 15 as being longer in duration relative to the previous APP indicated pacing interval T 14 .
  • the intrinsic coefficient a of filter 515 controls the "attack slope" of the APP indicated heart rate as the APP indicated heart rate increases because of sensed intrinsic beats.
  • the paced coefficient b of filter 515 controls the "decay slope" of the APP indicated heart rate as the APP indicated heart rate decreases during periods of paced beats.
  • decreasing the value of a further beneath 1.0 increases the attack slope such that the APP indicated rate increases faster in response to sensed intrinsic beats, while decreasing the value of b toward 1.0 decreases the decay slope such that the APP indicated rate decreases more slowly during periods of paced beats.
  • the user selects a desired performance parameter (e.g., desired degree of overdrive pacing, desired attack slope, desired decay slope, etc.) from a conesponding range of possible values, and device 105 automatically selects the appropriate combination of coefficients of filter 515 to provide a filter setting that conesponds to the selected user-programmed performance parameter, as illustrated generally by Table 1. Other levels of programmability or different combinations of coefficients may also be used. Table 1. Example of Automatic Selection of Aspects of Filter Setting Based on a User-Programmable Performance Parameter.
  • Figure 10 illustrates that sensed atrial beats increase the APP indicated rate by an amount that is based on the sensed atrial heart rate.
  • the APP indicated rate will increase faster than for a slower and smaller increase in sensed atrial heart rate.
  • increases in the APP indicated rate do not depend solely on the sensed atrial heart rate. Instead, such increases in the APP indicated heart rate also depend on the previous value of the APP indicated heart rate. This provides a smoothing function so that the APP indicated heart rate is not overly sensitive to a single extremely premature atrial beat, changes in the atrial rate are more gradual, and the degree of such rate changes is programmably adjustable, as described above.
  • filter 515 operates continuously to provide continuous rate adjustment based on the APP indicated rate.
  • Figure 11 is a graph illustrating generally, by way of example, but not by way of limitation, one embodiment of selecting between more than one indicated pacing interval.
  • Figure 11 is similar to Figure 10 in some respects, but Figure 11 includes a second indicated pacing interval.
  • the first indicated pacing interval is the APP indicated pacing interval, described above
  • the second indicated pacing interval is a sensor indicated pacing interval, from an accelerometer, minute ventilation, or other indication of the patient's physiological need for increased cardiac output.
  • a selected indicated pacing interval is based on the shorter of the first and second indicated pacing intervals.
  • device 105 provides pacing pulses at the higher indicated pacing rate.
  • the first and second beats and the eighth through fifteenth beats are paced at the sensor indicated rate, because it is higher than the APP indicated atrial rate and the intrinsic (sensed) atrial rate.
  • the third, fourth, fifth and sixth atrial beats are sensed intrinsic beats that are sensed during the shorter of either of the APP and sensor indicated pacing intervals.
  • the seventh beat is paced at the APP indicated rate, because it is higher than the sensor indicated rate, and because no intrinsic beat is sensed during the APP indicated interval T 6 .
  • the ranges of both the sensor indicated rate and the APP indicated rate are limited so that they do not extend to rates higher than the URL or to rates lower than the LRL.
  • the above-described equations for filter 515 operate to increase the APP indicated rate toward the sensor-indicated rate when the sensor indicated rate is greater than the APP indicated rate, as illustrated by first through third and eighth through fifteenth beats in Figure 11.
  • the LRL and the URL are programmable by the user, such as by using remote programmer 125.
  • filter 515 includes variable coefficients such as, for example, coefficients that are a function of heart rate (or its conesponding time interval).
  • Figure 12 is a graph illustrating generally, by way of example, but not by way of limitation, one embodiment of using at least one of coefficients a and b as a function of one or more previous A-A intervals such as, for example, the most recent A-A interval, AA n .
  • a is less than 1.0 when AA n is at or near the lower rate limit (e.g., 1000 millisecond interval or 60 beats/minute), and a is greater than 1.0 when AA n is at or near the upper rate limit (e.g., 500 millisecond interval or 120 beats/minute).
  • b is close to 1.0 when AA n is at or near the lower rate limit, and b is greater than 1.0 when AA n is at or near the upper rate limit.
  • using a smaller value of b at lower rates will decrease the pacing rate more slowly for paced events; using a larger value of b at higher rates decreases pacing rate more quickly for paced events.
  • the above-described system provides, among other things, a cardiac rhythm management system including an atrial pacing preference (APP) filter for promoting atrial pacing.
  • the APP filter controls the timing of delivery of atrial pacing pulses.
  • the atrial pacing pulses are delivered at a first indicated pacing rate, i.e., the APP-indicated rate, that is typically at a small amount above the intrinsic atrial heart rate.
  • the APP indicated pacing rate is increased until it becomes slightly faster than the intrinsic atrial heart rate.
  • the APP-indicated pacing rate is then gradually decreased to search for the underlying intrinsic atrial heart rate.
  • the APP filter again increases the APP indicated pacing rate until it becomes faster than the intrinsic atrial rate by a small amount.
  • the APP filter again increases the APP indicated pacing rate until it becomes faster than the intrinsic atrial rate by a small amount.
  • most atrial heart beats are paced, rather than sensed.
  • This decreases the likelihood of the occunence of an atrial tachyanhythmia, such as atrial fibrillation.
  • the decreased likelihood of atrial tachyanhythmia decreases the likelihood of inducing a ventricular anhythmia, either as a result of the atrial tachyanhythmia, or as the result of delivering a defibrillation shock to treat the atrial tachyanhythmia.

Abstract

A cardiac rhythm management system includes an atrial pacing preference (APP) filter for promoting atrial pacing. The APP filter includes an infinite impulse response (IIR) or other filter that controls the timing of delivery of atrial pacing pulses. The atrial pacing pulses are delivered at an APP-indicated pacing rate that is typically at a small amount above the intrinsic atrial heart rate. For sensed beats, the APP indicated rate is increased until it becomes slightly faster than the intrinsic atrial heart rate. The APP-indicated pacing rate is then gradually decreased to search for the underlying intrinsic atrial heart rate. Then, after a sensed atrial beat, the APP filter again increases the pacing rate until it becomes faster than the intrinsic atrial rate by a small amount. As a result, most atrial heart beats are paced, rather than sensed. This decreases the likelihood of the occurrence of an atrial tachyarrhythmia, such as atrial fibrillation. The decreased likelihood of atrial tachyarrhythmia, in turn, decreases the likelihood of inducing a ventricular arrhythmia, either as a result of the atrial tachyarrhythmia, or as the result of delivering a defibrillation shock to treat the atrial tachyarrhythmia.

Description

SYSTEM PROMOTING ATRTAT, PACTNG
Cross Reference To Related Applications
This application is related to the following co-pending, commonly assigned patent applications: "Method and Apparatus for Treating Irregular Ventricular Contractions Such as During Atrial Arrhythmia," serial number 09/316,515 (Attorney Docket No. 00279.112US1); "Cardiac Rhythm
Management System With Atrial Shock Timing Optimization," serial number 09/316,741 (Attorney Docket No. 00279.142US1); and "System Providing Ventricular Pacing and Biventricular Coordination," serial number 09/316,588 (Attorney Docket No. 00279.160US1); each of which are filed on even date herewith, each of which disclosure is herein incorporated by reference in its entirety.
Technical Field This invention relates generally to cardiac rhythm management systems and particularly, but not by way of limitation, to a cardiac rhythm management system promoting atrial pacing.
Background When functioning properly, the human heart maintains its own intrinsic rhythm, and is capable of pumping adequate blood throughout the body's circulatory system. However, some people have irregular cardiac rhythms, referred to as cardiac arrhythmias. Such arrhythmias result in diminished blood circulation. One mode of treating cardiac arrhythmias uses drug therapy. Drug therapy is not always effective for treating arrhythmias of certain patients. For such patients, an alternative mode of treatment is needed. One such alternative mode of treatment includes the use of a cardiac rhythm management system. Such systems are often implanted in the patient and deliver therapy to the heart. Cardiac rhythm management systems include, among other things, pacemakers, also referred to as pacers. Pacers deliver timed sequences of low energy electrical stimuli, called pace pulses, to the heart, such as via a transvenous leadwire or catheter (referred to as a "lead") having one or more electrodes disposed in or about the heart. Heart contractions are initiated in response to such pace pulses (this is referred to as "capturing" the heart). By properly timing the delivery of pace pulses, the heart can be induced to contract in proper rhythm, greatly improving its efficiency as a pump. Pacers are often used to treat patients with bradyarrhythmias, that is, hearts that beat too slowly, or irregularly. Cardiac rhythm management systems also include cardioverters or defibrillators that are capable of delivering higher energy electrical stimuli to the heart. Defibrillators are often used to treat patients with tachyarrhythmias, that is, hearts that beat too quickly. Such too-fast heart rhythms also cause diminished blood circulation because the heart isn't allowed sufficient time to fill with blood before contracting to expel the blood. Such pumping by the heart is inefficient. A defibrillator is capable of delivering an high energy electrical stimulus that is sometimes referred to as a defibrillation shock. The shock interrupts the tachyarrhythmia, allowing the heart to reestablish a normal rhythm for the efficient pumping of blood. In addition to pacers, cardiac rhythm management systems also include, among other things, pacer/defibrillators that combine the functions of pacers and defibrillators, drug delivery devices, and any other systems or devices for diagnosing or treating cardiac arrhythmias.
One problem faced by cardiac rhythm management systems is the proper treatment of atrial tachyarrhythmias, such as atrial fibrillation. Atrial fibrillation is a common cardiac arrhythmia which reduces the pumping efficiency of the heart, though not to as great a degree as in ventricular fibrillation. However, this reduced pumping efficiency requires the ventricle to work harder, which is particularly undesirable in sick patients that cannot tolerate additional stresses. As a result of atrial fibrillation, patients must typically limit their activity and exercise.
Although atrial fibrillation, by itself, is usually not life-threatening, prolonged atrial fibrillation may be associated with strokes, which are thought to be caused by blood clots forming in areas of stagnant blood flow. Treating such blood clots requires the use of anticoagulants. Atrial fibrillation may also cause pain, dizziness, and other irritation to the patient. For this reason, atrial fibrillation is typically treated with a low energy defibrillation shock to enable the resumption of normal atrial heart rhythms. An even more serious problem, however, is the risk that atrial fibrillation may induce irregular ventricular heart rhythms by processes that are yet to be fully understood. Such induced ventricular arrhythmias compromise pumping efficiency even more drastically than atrial arrhythmias and, in some instances, may be life-threatening. Moreover, treating atrial fibrillation by a defibrillation shock may also induce dangerous ventricular arrhythmias. For these and other reasons, there is a need for safe and more effective atrial therapy that prevents the occurrence of atrial tachyarrhythmias, such as atrial fibrillation, thereby avoiding inducing ventricular arrhythmia as the result of the atrial tachyarrhythmia or its treatment.
Summary This document discloses, among other things, a cardiac rhythm management system including an atrial pacing preference (APP) filter for promoting atrial pacing. The APP filter controls the timing of delivery of atrial pacing pulses. The atrial pacing pulses are delivered at a first indicated pacing rate, i.e., the APP-indicated rate, that is typically at a small amount above the intrinsic atrial heart rate. For sensed beats, the APP-indicated rate is increased until it becomes slightly faster than the intrinsic atrial heart rate of the sensed atrial beat. The APP-indicated pacing rate is then gradually decreased to search for the underlying intrinsic atrial heart rate. Then, after a sensed atrial beat, the APP filter again elevates the APP-indicated pacing rate until it is above the intrinsic heart atrial rate by a small amount. As a result, most atrial heart beats are paced, rather than sensed. This is believed to decrease the likelihood of the occurrence of an atrial tachyarrhythmia, such as atrial fibrillation. The decreased likelihood of atrial tachyarrhythmia, in turn, decreases the likelihood of inducing a ventricular arrhythmia, either as a result of the atrial tachyarrhythmia, or as the result of delivering a defibrillation shock to treat the atrial tachyarrhythmia.
In one embodiment, the cardiac rhythm management system includes a method comprising: (1) obtaining A- A intervals between atrial beats, (2) computing a first indicated pacing interval based at least on a most recent A-A interval duration and a previous value of the first indicated pacing interval, and (3) providing atrial pacing therapy, based on the first indicated pacing interval. In another embodiment, the cardiac rhythm management system includes an atrial sensing circuit, an atrial therapy circuit, and a controller. The controller includes an A-A interval timer, a first register, for storing a first indicated pacing interval, and a filter, updating the first indicated pacing interval based on the A- A interval timer and the first register. The atrial therapy circuit provides pacing therapy based at least partially on the first indicated pacing interval. Other aspects of the invention will be apparent on reading the following detailed description of the invention and viewing the drawings that form a part thereof, each of which are not to be taken in a limiting sense; the scope of the present invention is defined by the appended claims and their equivalents.
Brief Description of the Drawings In the drawings, like numerals describe substantially similar components throughout the several views. Like numerals having different letter suffixes represent different instances of substantially similar components. Figure 1 is a schematic drawing illustrating one embodiment of portions of a cardiac rhythm management system and an environment in which it is used. Figure 2 is a schematic drawing illustrating one embodiment of a cardiac rhythm management device coupled by leads to portions of a heart.
Figure 3 is a schematic diagram illustrating generally one embodiment of portions of a cardiac rhythm management device which is coupled to a heart.
Figure 4 is a schematic diagram illustrating generally one embodiment of a controller that includes several different inputs to modify the rate at which pacing or other therapy is delivered.
Figure 5 is a schematic diagram illustrating generally one conceptualization of portions of a controller.
Figure 6 is a signal flow diagram illustrating generally one embodiment of operating a filter.
Figure 7 is a signal flow diagram illustrating generally aspects of another conceptualization of operating the filter. Figure 8 is a signal flow diagram illustrating generally aspects of a further conceptualization of operating the filter.
Figure 9 is a schematic diagram illustrating generally another conceptualization of portions of a controller. Figure 10 is a graph illustrating generally one embodiment of operating a filter to provide a first indicated rate, such as an Atrial Pacing Preference ("APP") indicated rate, for successive atrial heart beats.
Figure 11 is a graph illustrating generally another embodiment of operating a filter to provide a first indicated pacing rate, such as an APP indicated rate, and delivering therapy based on the first indicated pacing rate and based on a second indicated pacing rate, such as a sensor indicated rate.
Figure 12 is a graph illustrating generally one embodiment of using at least one of coefficients a and b as a function of heart rate (or a conesponding time interval).
Detailed Description In the following detailed description, reference is made to the accompanying drawings which form a part hereof, and in which is shown by way of illustration specific embodiments in which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is to be understood that the embodiments may be combined, or that other embodiments may be utilized and that structural, logical and electrical changes may be made without departing from the spirit and scope of the present invention. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims and their equivalents. In the drawings, like numerals describe substantially similar components throughout the several views. Like numerals having different letter suffixes represent different instances of substantially similar components. General Overview
This document describes, among other things, a cardiac rhythm management system including an atrial pacing preference (APP) filter for promoting atrial pacing over atrial sensing. The APP filter controls the timing of delivery of atrial pacing pulses. The atrial pacing pulses are delivered at a first indicated pacing rate, i.e., the APP-indicated pacing rate, that is typically at a small amount above the intrinsic atrial heart rate. The APP-indicated rate is slowly decreased to search for the underlying intrinsic atrial heart rate. Then, after a sensed atrial beat, the APP filter increases the pacing rate until it becomes faster than the intrinsic atrial rate by a small amount. As a result, most atrial heart beats are paced, rather than sensed. This decreases the likelihood of the occunence of an atrial tachyarrhythmia, such as atrial fibrillation. The decreased likelihood of atrial tachyanhythmia, in turn, decreases the likelihood of inducing a ventricular arrhythmia, either as a result of the atrial tachyarrhythmia, or as the result of delivering a defibrillation shock to treat the atrial tachyanhythmia.
Example Embodiments Figure 1 is a schematic drawing illustrating, by way of example, but not by way of limitation, one embodiment of portions of a cardiac rhythm management system 100 and an environment in which it is used. In Figure 1, system 100 includes an implantable cardiac rhythm management device 105, also refened to as an electronics unit, which is coupled by an intravascular endocardial lead 110, or other lead, to a heart 115 of patient 120. System 100 also includes an external programmer 125 providing wireless communication with device 105 using a telemetry device 130. Catheter lead 110 includes a proximal end 135, which is coupled to device 105, and a distal end 140, which is coupled to one or more portions of heart 115.
Figure 2 is a schematic drawing illustrating, by way of example, but not by way of limitation, one embodiment of device 105 coupled by one or more leads, such as leads 110A-B, to heart 115, which includes a right atrium 200 A, a left atrium 200B, a right ventricle 205A, a left ventricle 205B, and a coronary sinus 220 extending from right atrium 200A. In this embodiment, atrial lead 110A includes electrodes (electrical contacts) disposed in, around, or near right atrium 200A of heart 115, such as ring electrode 225 and tip electrode 230, for sensing signals and or delivering pacing therapy to the right atrium 200A. Lead 110A optionally also includes additional electrodes, such as for delivering atrial and/or ventricular cardioversion/defibrillation and/or pacing therapy to heart 115.
In Figure 2, a ventricular lead HOB includes one or more electrodes, such as tip electrode 235 and ring electrode 240, for sensing signals and/or delivering pacing therapy. Lead HOB optionally also includes additional electrodes, such as for delivering atrial and/or ventricular cardioversion/defibrillation and/or pacing therapy to heart 115. Device 105 includes components that are enclosed in a hermetically-sealed can 250. Additional electrodes may be located on the can 250, or on an insulating header 255, or on other portions of device 105, for providing unipolar pacing and/or defibrillation energy in conjunction with the electrodes disposed on or around heart 115. Other forms of electrodes include meshes and patches which may be applied to portions of heart 115 or which may be implanted in other areas of the body to help "steer" electrical cunents produced by device 105. The present method and apparatus will work in a variety of configurations and with a variety of electrical contacts or "electrodes."
Example Cardiac Rhythm Management Device Figure 3 is a schematic diagram illustrating generally, by way of example, but not by way of limitation, one embodiment of portions of device 105, which is coupled to heart 115. Device 105 includes a power source 300, an atrial sensing circuit 305, an atrial therapy circuit 310, and a controller 325. Device 105 also optionally includes a ventricular sensing circuit 315 and a ventricular therapy circuit 320.
Atrial sensing circuit 305 is coupled by atrial lead 110A to heart 115 for receiving, sensing, and/or detecting electrical atrial heart signals. Such atrial heart signals include atrial activations (also refened to as atrial depolarizations or P-waves), which conespond to atrial contractions. Such atrial heart signals include normal atrial rhythms, and abnormal atrial rhythms including atrial tachyanhythmias, such as atrial fibrillation, and other atrial activity. Atrial sensing circuit 305 provides one or more signals to controller 325, via node/bus 327, based on the received atrial heart signals. Such signals provided to controller 325 indicate, among other things, the presence of sensed intrinsic atrial heart contractions.
Atrial therapy circuit 310 provides atrial pacing therapy, as appropriate, to electrodes located at or near one of the atria 200 of heart 115 for obtaining resulting evoked atrial depolarizations. In one embodiment, atrial therapy circuit 310 also provides cardioversion/defibrillation therapy, as appropriate, to electrodes located at or near one of the atria 200 of heart 115, for terminating atrial fibrillation and or other atrial tachyanhythmias.
Ventricular sensing circuit 315 is coupled by ventricular lead HOB to heart 115 for receiving, sensing, and/or detecting electrical ventricular heart signals, such as ventricular activations (also refened to as ventricular depolarizations or R-waves), which conespond to ventricular contractions. Such ventricular heart signals include normal ventricular rhythms, and abnormal ventricular rhythms, including ventricular tachyanhythmias, such as ventricular fibrillation, and other ventricular activity, such as inegular ventricular contractions resulting from conducted signals from atrial fibrillation. Ventricular sensing circuit 315 provides one or more signals to controller 325, via node/bus 327, based on the received ventricular heart signals. Such signals provided to controller 325 indicate, among other things, the presence of ventricular depolarizations, whether regular or inegular in rhythm.
Ventricular therapy circuit 320 provides ventricular pacing therapy, as appropriate, to electrodes located at or near one of the ventricles 205 of heart 115 for obtaining resulting evoked ventricular depolarizations. In one embodiment, ventricular therapy circuit 320 also provides cardioversion/defibrillation therapy, as appropriate, to electrodes located at or near one of the ventricles 205 of heart 115, for terminating ventricular fibrillation and/or other ventricular tachyanhythmias .
Controller 325 controls the delivery of therapy by atrial therapy circuit 310, ventricular therapy circuit 320, and/or other circuits, based on heart activity signals received from atrial sensing circuit 305 and ventricular sensing circuit 315, as discussed below. Controller 325 includes various modules, which are implemented either in hardware or as one or more sequences of steps carried out on a microprocessor or other controller. Such modules are illustrated separately for conceptual clarity; it is understood that the various modules of controller 325 need not be separately embodied, but may be combined and or otherwise implemented, such as in software/firmware.
In general terms, sensing circuits 305 and 310 sense electrical signals from heart tissue in contact with the catheter leads 110A-B to which these sensing circuits 305 and 310 are coupled. Sensing circuits 305 and 310 and/or controller 325 process these sensed signals. Based on these sensed signals, controller 325 issues control signals to therapy circuits, such as atrial therapy circuit 310 and/or ventricular therapy circuit 320, if necessary, for the delivery of electrical energy (e.g., pacing and/or defibrillation pulses) to the appropriate electrodes of leads 110A-B. Controller 325 may include a microprocessor or other controller for execution of software and/or firmware instructions. The software of controller 325 may be modified (e.g., by remote external programmer 105) to provide different parameters, modes, and/or functions for the implantable device 105 or to adapt or improve performance of device 105.
In one further embodiment, one or more sensors, such as sensor 330, may serve as inputs to controller 325 for adjusting the rate at which pacing or other therapy is delivered to heart 115. One such sensor 330 includes an accelerometer that provides an input to controller 325 indicating increases and decreases in physical activity, for which controller 325 increases and decreases pacing rate, respectively. Another such sensor includes an impedance measurement, obtained from body electrodes, which provides an indication of increases and decreases in the patient's respiration, for example, for which controller 325 increases and decreases pacing rate, respectively. Any other sensor 330 providing an indicated pacing rate can be used.
Figure 4 is a schematic diagram illustrating generally, by way of example, but not by way of limitation, one embodiment of controller 325 that includes several different inputs to modify the rate at which pacing or other therapy is delivered. For example, Input #1 may provide information about atrial heart rate, Input #2 may provide information about ventricular heart rate, Input #3 may provide an accelerometer-based indication of activity, and Input #4 may provide an impedance-based indication of respiration, such as minute ventilation. Based on at least one of these and/or other inputs, controller 325 provides an output indication of pacing rate as a control signal delivered to a therapy circuit, such as to one or more of atrial therapy circuit 310 and ventricular therapy circuit 320. Atrial therapy circuit 310 and ventricular therapy circuit 320 issue pacing pulses based on one or more such control signals received from controller 325. Control of the pacing rate may be performed by controller 325, either alone or in combination with peripheral circuits or modules, using software, hardware, firmware, or any combination of the like. The software embodiments provide flexibility in how inputs are processed and may also provide the opportunity to remotely upgrade the device software while still implanted in the patient without having to perform surgery to remove and/or replace the device 105. Controller Example 1 Figure 5 is a schematic diagram illustrating generally, by way of example, but not by way of limitation, one conceptualization of portions of controller 325. At least one signal from atrial sensing circuit 305 is received by atrial event module 500, which recognizes the occurrence of atrial events included within the signal. Such events are also refened to as "beats," "activations," "depolarizations," "P-waves," or "contractions. " Atrial event module 500 detects intrinsic events (also refened to as sensed events) from the signal obtained from atrial sensing circuit 305. Atrial event module 500 also detects evoked events (resulting from a pace) either from the signal obtained from atrial sensing circuit 305, or preferably from an atrial pacing control signal obtained from pacing control module 505, which also triggers the delivery of a pacing stimulus by atrial therapy circuit 310. Thus, atrial events include both intrinsic/sensed events and evoked/paced events. A time interval between successive atrial events, refened to as an A-A interval, is recorded by a first timer, such as A-A interval timer 510. A filter 515 computes a "first indicated pacing interval," i.e., one indication of a desired time interval between atrial events or, stated differently, a desired atrial heart rate. The first indicated pacing interval is also refened to as an atrial pacing preference (APP) indicated pacing interval. In various embodiments, filter 515 includes an averager, a weighted averager, a median filter, an infinite impulse (IIR) filter, a finite impulse response (FIR) filter, or any other analog or digital signal processing circuit providing the desired signal processing described more particularly below. In one embodiment, filter 515 computes a new value of the first indicated pacing interval (also refened to as the APP-indicated pacing interval) based on the duration of the most recent A-A interval recorded by timer 510 and on a previous value of the first indicated pacing interval stored in first indicated pacing interval register 520. Register 520 is then updated by storing the newly computed first indicated pacing interval in register 520. Based on the first indicated pacing interval stored in register 520, pacing control module 505 delivers control signals to atrial therapy circuit 310 for delivering therapy, such as pacing stimuli, at the APP-indicated atrial heart rate conesponding to the inverse of the duration of the first indicated pacing interval.
Filter Example 1 In general terms, for one embodiment, device 105 obtains A-A intervals between successive sensed or evoked atrial beats. Device 105 computes a new first indicated pacing interval based at least in part on the duration of the most recent A-A interval and a previous value of the first indicated pacing interval. Device 105 provides atrial pacing therapy delivered at a rate conesponding to the inverse of the duration of the first indicated pacing interval. Figure 6 is a signal flow diagram illustrating generally, by way of example, but not by way of limitation, one embodiment of operating filter 515. Upon the occunence of a sensed or evoked atrial beat, timer 510 provides filter 515 with the duration of the A-A interval concluded by that beat, which is refened to as the most recent A-A interval (AAn). Filter 515 also receives the previous value of the first indicated pacing interval (E„_y) stored in register 520. The most recent A-A interval AAn and the previous value of the first indicated pacing interval Tn_, are each scaled by respective constants A and B, and then summed to obtain a new value of the first indicated pacing interval (Tn), which is stored in register 520 and provided to pacing control module 505. In one embodiment, the coefficients A and B are different values, and are either programmable, variable, or constant.
If no atrial beat is sensed during the new first indicated pacing interval Tn, which is measured as the time from the occunence of the atrial beat concluding the most recent A-A interval AAn, then pacing control module 505 instructs atrial therapy circuit 310 to deliver an atrial pacing pulse upon the expiration of the new first indicated pacing interval Tn. In one embodiment, operation of the filter is described by Tn = A-AAn + B-Tn_„ where A and B are coefficients (also refened to as "weights"), AAn is the most recent A-A interval duration, and _Tπ_. is the previous value of the first indicated pacing interval. Initialization of filter 515 includes seeding the filter by storing, in register
520, an initial interval value. In one embodiment, register 520 is initialized to an interval value conesponding to a lower rate limit (LRL), i.e., a minimum rate at which pacing pulses are delivered by device 105. Register 520 could alternatively be initialized with any other suitable value.
Filter Example 2 In one embodiment, operation of filter 515 is based on whether the beat concluding the most recent A-A interval AAn is a sensed/intrinsic beat or a paced/evoked beat. In this embodiment, the pacing control module 505, which controls the timing and delivery of pacing pulses, provides an input to filter 515 that indicates whether the most recent A-A interval AAn was concluded by an evoked beat initiated by a pacing stimulus delivered by device 105, or was concluded by an intrinsic beat sensed by atrial sensing circuit 305.
In general terms, if the most recent A-A interval AAn is concluded by a sensed intrinsic beat, then filter 515 provides a new first indicated pacing interval Tn that is adjusted from the value of the previous first indicated pacing interval Tn_, such as, for example, decreased by an amount that is based at least partially on the duration of the most recent A-A interval AAn and on the duration of the previous value of the first indicated pacing interval Tn_,. If, however, the most recent A-A interval AAn is concluded by a paced/evoked beat, then filter 515 provides a new first indicated pacing interval T„ that is increased from the value of the previous first indicated pacing interval _T„_7, such as, for example, by an amount that is based at least partially on the duration of the most recent A-A interval AAn and on the duration of the previous value of the first indicated pacing interval Tn . If no atrial beat is sensed during the new first indicated pacing interval Tn, which is measured as the time from the occunence of the atrial beat concluding the most recent A-A interval AAn, then pacing control module 505 instructs atrial therapy circuit 310 to deliver an atrial pacing pulse upon the expiration of the new first indicated pacing interval Tn.
Figure 7 is a signal flow diagram, illustrating generally, by way of example, but not by way of limitation, another conceptualization of operating filter 515, with certain differences from Figure 6 more particularly described below. In this embodiment, the pacing control module 505, which controls the timing and delivery of pacing pulses, provides an input to filter 515 that indicates whether the most recent A-A interval AAn was concluded by an evoked beat initiated by a pacing stimulus delivered by device 105, or was concluded by an intrinsic beat sensed by atrial sensing circuit 305.
If the most recent A-A interval AAn was concluded by an intrinsic beat, then the most recent A-A interval, AAn, and the previous value of the first indicated pacing interval, Tn_,, are each scaled by respective constants A and B, and then summed to obtain the new value of the first indicated pacing interval Tn, which is stored in register 520 and provided to pacing control module 505. Alternatively, if the most recent A-A interval AAn was concluded by an evoked/paced beat, then the most recent A-A interval AAn and the previous value of the first indicated pacing interval Tn_, are each scaled by respective constants C and D, and then summed to obtain the new value of the first indicated pacing interval Tn, which is stored in register 520 and provided to pacing control module 505. In one embodiment, the coefficients C and D are different from each other, and are either programmable, variable, or constant. In a further embodiment, the coefficient C is a different value from the coefficient A, and or the coefficient D is a different value than the coefficient B, and these coefficients are either programmable, variable, or constant. In another embodiment, the coefficient D is the same value as the coefficient B.
In one embodiment, operation of filter 515 is described by Tn = A-AAn + B-Tn_j, κϊAAn is concluded by an intrinsic beat, and is described by Tn = AAn + D-Tn_ , iϊAAn is concluded by a paced beat, where A, B, C and D are coefficients (also refened to as "weights"), AAn is the most recent A-A interval duration, Tn is the new value of the first indicated pacing interval, and Tn_, is the previous value of the first indicated pacing interval. If no atrial beat is sensed during the new first indicated pacing interval Tn, which is measured as the time from the occunence of the atrial beat concluding the most recent A-A interval AAn, then pacing control module 505 instructs atrial therapy circuit 310 to deliver an atrial pacing pulse upon the expiration of the new first indicated pacing interval Tn.
Filter Example 3 In another embodiment, these coefficients can be more particularly described using an intrinsic coefficient (a), a paced coefficient (b), and a weighting coefficient (w). In one such embodiment, A = a-w, B = (l-w), C = b-w, and D = (l-w). In one example, operation of the filter 515 is described by Tn = a-w-AAn + (l-w)-Tn_j, \ϊAAn is concluded by an intrinsic beat, otherwise is described by Tn = b-w-AAn + (\-w)-Tn_„ iϊAAn is concluded by a paced beat, as illustrated generally, by way of example, but not by way of limitation, in the signal flow graph of Figure 8. If no atrial beat is sensed during the new first indicated pacing interval Tn, which is measured as the time from the occunence of the atrial beat concluding the most recent A-A interval AAn, then pacing control module 505 instructs atrial therapy circuit 310 to deliver an atrial pacing pulse upon the expiration of the new first indicated pacing interval Tn. In one embodiment, the coefficients a and b are different from each other, and are either programmable, variable, or constant.
The above-described parameters (e.g., A, B, C, D, a, b, v) are stated in terms of time intervals (e.g., AAn, Tn, Tn_j). However, an alternate system may produce results in terms of rate, rather than time intervals, without departing from the present method and apparatus. In one embodiment, weighting coefficient vv, intrinsic coefficient a, arid paced coefficient b, are variables.
Different selections of vv, a, and b, will result in different operation of the present method and apparatus. For example, as vv increases the weighting effect of the most recent A-A interval AAn increases and the weighting effect of the previous first indicated pacing rate Tn_, decreases. In one embodiment, vv = 1/16 = 0.0625. In another embodiment, vv = 1/32. Another possible range for v is from vv = V_ to vv = 1/1024. A further possible range for vv is from v ~ 0 to vv= 1. Other values of vv, which need not include division by powers of two, may be substituted without departing from the present method and apparatus.
In one embodiment, intrinsic coefficient a, is selected to be less than (or, alternatively, less than or equal to) 1.0. In one example, the intrinsic coefficient a is selected to be lesser in value than the pacing coefficient b. In one embodiment, a~ 0.6 and b~ 1.5. In another embodiment, a = 1.0 and b = 1.05. One possible range for a is from a = 0.6 to a = 1.0, and for b is from b = 1.05 to b = 1.5. The coefficients may vary without departing from the present method and apparatus.
In one embodiment, for a < 1.0 filter 515 provides a new first indicated pacing interval Tπ that is at least slightly shorter than the expected intrinsic A-A interval being measured by timer 515. Thus, filter 515 operates to promote atrial pacing by increasing the APP-indicated rate until it becomes slightly faster than the intrinsic atrial rate. The APP-indicated rate is then gradually decreased to search for the underlying intrinsic atrial heart rate. After a sensed atrial beat, the APP filter 515 again increases the APP indicated pacing rate until it becomes faster than the intrinsic atrial rate by a small amount. As a result, most atrial heart beats are paced, rather than sensed. This decreases the likelihood of the occunence of an atrial tachyanhythmia, such as atrial fibrillation. The decreased likelihood of atrial tachyanhythmia, in turn, decreases the likelihood of inducing a ventricular anhythmia, either as a result of the atrial tachyanhythmia, or as the result of delivering a defibrillation shock to treat the atrial tachyanhythmia.
Controller Example 2 Figure 9 is a schematic diagram illustrating generally, by way of example, but not by way of limitation, another conceptualization of portions of controller 325, with certain differences from Figure 5 more particularly described below. In Figure 9, controller 325 receives from sensor 330 a signal including information from which a physiologically desired heart rate (e.g., based on the patient's activity, respiration, or any other suitable indicator of metabolic need) can be derived. The sensor signal is digitized by an A/D converter 900. The digitized signal is processed by a sensor rate module 905, which computes a desired heart rate that is expressed in terms of a second indicated pacing interval stored in register 910. The second indicated pacing interval is also refened to as a sensor-indicated pacing interval, or if expressed in terms of rate, a sensor-indicated pacing rate.
Pacing control module 505 delivers a control signal, which directs atrial therapy circuit 310 to deliver a pacing pulse, based on either (or both) of the first or second indicated pacing intervals, stored in registers 520 and 910, respectively. In one embodiment, pacing control module 505 includes a selection module 915 that selects between the new first indicated pacing interval Tn and the sensor-based second indicated pacing interval. In one embodiment, selection module 915 selects the shorter of the first and second indicated pacing intervals as the selected indicated pacing interval Sπ. If no atrial beat is sensed during the selected indicated pacing interval S„, which is measured as the time from the occunence of the atrial beat concluding the most recent A-A interval AAn, then pacing control module 505 instructs atrial therapy circuit 320 to deliver an atrial pacing pulse upon the expiration of the selected indicated pacing interval Sn.
In general terms, for this embodiment, the atrium is paced at the higher of the sensor indicated rate and the APP-indicated rate. If, for example, the patient is resting, such that the sensor indicated rate is lower than the patient's intrinsic rate, then atrial pacing pulses will be delivered at the APP-indicated rate, which is typically slightly higher than the patient's intrinsic atrial heart rate. But if, for example, the patient is active, such that the sensor indicated rate is higher than the APP-indicated rate, then pacing pulses generally will be delivered at the sensor indicated rate. In an alternative embodiment, the pacing rate is determined by blending the sensor indicated rate and the APP-indicated rate, rather than by selecting the higher of these two indicated rates (i.e., the shorter of the first and second indicated pacing intervals). In one such example, selection module 915 applies predetermined or other weights to the first and second indicated pacing intervals to compute the selected pacing interval S„.
Filter Rate Behavior Example 1 Figure 10 is a graph illustrating generally, by way of example, but not by way of limitation, one embodiment of an APP-indicated rate for successive atrial heart beats for one mode of operating filter 515. As discussed above, the APP- indicated rate is simply the frequency, between atrial heart beats, associated with the first indicated pacing interval. Stated differently, the APP indicated rate is inversely related to the duration of the first indicated pacing interval. If pacing is based solely on the APP indicated rate, pacing control module 505 directs atrial therapy circuit 310 to issue a pacing pulse after the time since the last atrial beat equals or exceeds the first indicated pacing interval. However, as described above, in certain embodiments, pacing control module 505 directs atrial therapy circuit 310 to issue a pacing pulse based on factors other than the APP indicated rate such as for, example, based on the sensor indicated rate. In the example illustrated in Figure 10, a first paced atrial beat, indicated by a "P" was issued upon expiration of the first indicated pacing interval (i.e., the APP indicated pacing interval) T0, as computed based on a previous atrial beat. In one embodiment, the new APP indicated pacing interval T, is computed based on the duration of most recent A-A interval AA, and a previous value of the APP indicated pacing interval T0, as discussed above. In Figure 10, the new APP indicated pacing interval T, conesponds to a lower rate limit (LRL) time interval. In one embodiment, as illustrated in Figure 10, the allowable range of the APP indicated pacing interval is limited so that the APP indicated pacing interval does not exceed the duration of the LRL time interval, and so that the APP indicated pacing interval is not shorter than the duration of an upper rate limit (URL) time interval.
In the example of Figure 10, the second atrial beat is also paced upon expiration of the APP indicated pacing interval T,. In one embodiment, the new APP indicated pacing interval T2 is computed based on the duration of most recent A-A interval AA2 and a previous value of the APP indicated pacing interval, T,, as discussed above. The first and second atrial beats are paced beats because the APP indicated atrial heart rate is higher than the underlying intrinsic atrial heart rate.
The third atrial beat is sensed well before expiration of the APP indicated pacing interval T2, such that no pacing pulse is issued. For the sensed third atrial beat, filter 515 computes the new APP indicated pacing interval T3 as being shorter in duration relative to the previous APP indicated pacing interval T2. The fourth, fifth, and sixth atrial beats are sensed before expiration of the
APP indicated pacing interval T3, T4, and T5, respectively For each of the sensed fourth, fifth, and sixth atrial beats, filter 515 computes a new APP indicated pacing interval as being shorter in duration relative to the previous APP indicated pacing interval. At the time of the seventh atrial beat, the APP indicated heart rate has increased above the underlying intrinsic atrial heart rate, such that the seventh atrial beat is paced upon expiration of the APP indicated pacing interval T6. Because the seventh atrial beat is paced, rather than sensed, the new APP indicated pacing interval T7 is computed as being longer than the previous APP indicated pacing interval T6.
Similarly, the eighth and ninth atrial beats are each paced upon expiration of the conesponding APP indicated pacing interval, i.e., T7, and Ts, respectively. Each APP indicated pacing interval T7, and T8 is longer than the conesponding previous APP indicated pacing interval, i.e., T6, and T7, respectively. In this way, the APP indicated atrial heart rate is gradually decreased to search for the underlying intrinsic atrial heart rate.
At the time of the tenth atrial beat, the APP indicated heart rate has been lowered sufficiently to allow the sensing of the tenth atrial beat. The tenth atrial beat is sensed before expiration of the APP indicated pacing interval T9, such that no pacing pulse is issued. For the sensed tenth atrial beat, filter 515 computes the new APP indicated pacing interval T10 as being shorter in duration relative to the previous APP indicated pacing interval T9. The eleventh atrial beat is paced upon expiration of the APP indicated pacing interval T10. For the paced eleventh atrial beat, filter 515 computes the new APP indicated pacing interval Tu as being longer in duration relative to the previous APP indicated pacing interval Tw. Similarly, the twelfth and thirteenth atrial beats are each paced upon expiration of the conesponding APP indicated pacing interval, i.e., T,„ and T12, respectively. Each APP indicated pacing interval T12, and T13 is longer than the conesponding previous APP indicated pacing interval, i.e., Tu, and T12, respectively. In this way, the APP indicated atrial heart rate is gradually decreased to find the underlying intrinsic atrial heart rate. The fourteenth atrial beat is sensed before expiration of the APP indicated pacing interval T13, such that no pacing pulse is issued. For the sensed fourteenth atrial beat, filter 515 computes the new APP indicated pacing interval Tl4 as being shorter in duration relative to the previous APP indicated pacing interval TI3. The fifteenth atrial beat is paced upon expiration of the APP indicated pacing interval T14. For the paced fifteenth atrial beat, filter 515 computes the new APP indicated pacing interval T15 as being longer in duration relative to the previous APP indicated pacing interval T14.
The intrinsic coefficient a of filter 515 controls the "attack slope" of the APP indicated heart rate as the APP indicated heart rate increases because of sensed intrinsic beats. The paced coefficient b of filter 515 controls the "decay slope" of the APP indicated heart rate as the APP indicated heart rate decreases during periods of paced beats. In one embodiment, in which a < 1.0 and b > 1.0, decreasing the value of a further beneath 1.0 increases the attack slope such that the APP indicated rate increases faster in response to sensed intrinsic beats, while decreasing the value of b toward 1.0 decreases the decay slope such that the APP indicated rate decreases more slowly during periods of paced beats. Conversely, for a < 1.0 and b > 1.0, increasing the value of a toward 1.0 decreases the attack slope such that the APP indicated rate increases more slowly in response to sensed intrinsic beats, while increasing the value of b from 1.0 increases the decay slope such that the APP indicated rate decreases more quickly during periods of paced beats. In one embodiment, for a < 1.0 and b > 1.0, decreasing both a and b increases the APP indicated rate such that the APP indicated rate is higher above the mean intrinsic rate. Because the APP indicated rate is higher, variability in the intrinsic heart rate is less likely to result in sensed events. On the other hand, for a < 1.0 and b > 1.0, increasing both a and b decreases the APP indicated rate such that it is closer to, the mean intrinsic rate. Because the APP indicated rate is closer to the mean intrinsic rate, the same degree of variability in the intrinsic heart rate is more likely to result in sensed events. Thus, by optimizing the coefficients of filter 515, as discussed above, it is possible to obtain more intrinsic beats than paced beats for a particular degree of variability in the patient's heart rate. In one embodiment, these coefficients are programmable by the user, such as by using remote programmer 125. In another embodiment, the user selects a desired performance parameter (e.g., desired degree of overdrive pacing, desired attack slope, desired decay slope, etc.) from a conesponding range of possible values, and device 105 automatically selects the appropriate combination of coefficients of filter 515 to provide a filter setting that conesponds to the selected user-programmed performance parameter, as illustrated generally by Table 1. Other levels of programmability or different combinations of coefficients may also be used. Table 1. Example of Automatic Selection of Aspects of Filter Setting Based on a User-Programmable Performance Parameter.
Figure imgf000021_0001
Figure 10 illustrates that sensed atrial beats increase the APP indicated rate by an amount that is based on the sensed atrial heart rate. Thus, for an abrupt and large increase in sensed atrial rate, the APP indicated rate will increase faster than for a slower and smaller increase in sensed atrial heart rate. However, increases in the APP indicated rate do not depend solely on the sensed atrial heart rate. Instead, such increases in the APP indicated heart rate also depend on the previous value of the APP indicated heart rate. This provides a smoothing function so that the APP indicated heart rate is not overly sensitive to a single extremely premature atrial beat, changes in the atrial rate are more gradual, and the degree of such rate changes is programmably adjustable, as described above. Moreover, in one embodiment, filter 515 operates continuously to provide continuous rate adjustment based on the APP indicated rate.
Filter Rate Behavior Example 2 Figure 11 is a graph illustrating generally, by way of example, but not by way of limitation, one embodiment of selecting between more than one indicated pacing interval. Figure 11 is similar to Figure 10 in some respects, but Figure 11 includes a second indicated pacing interval. In one embodiment, the first indicated pacing interval is the APP indicated pacing interval, described above, and the second indicated pacing interval is a sensor indicated pacing interval, from an accelerometer, minute ventilation, or other indication of the patient's physiological need for increased cardiac output.
In one embodiment, a selected indicated pacing interval is based on the shorter of the first and second indicated pacing intervals. Stated differently, device 105 provides pacing pulses at the higher indicated pacing rate. In the example illustrated in Figure 11, the first and second beats and the eighth through fifteenth beats are paced at the sensor indicated rate, because it is higher than the APP indicated atrial rate and the intrinsic (sensed) atrial rate. The third, fourth, fifth and sixth atrial beats are sensed intrinsic beats that are sensed during the shorter of either of the APP and sensor indicated pacing intervals. The seventh beat is paced at the APP indicated rate, because it is higher than the sensor indicated rate, and because no intrinsic beat is sensed during the APP indicated interval T6. In this embodiment, the ranges of both the sensor indicated rate and the APP indicated rate are limited so that they do not extend to rates higher than the URL or to rates lower than the LRL. In one embodiment, the above-described equations for filter 515 operate to increase the APP indicated rate toward the sensor-indicated rate when the sensor indicated rate is greater than the APP indicated rate, as illustrated by first through third and eighth through fifteenth beats in Figure 11. In an alternate embodiment, however, Tn = b-wAAn + (l-w)-Tn_,, ifAAn is concluded by a APP indicated paced beat, and Tn = Tn_j if AAn is concluded by a sensor indicated paced beat, thereby leaving the APP indicated rate unchanged for sensor indicated paced beats. In one embodiment, the LRL and the URL are programmable by the user, such as by using remote programmer 125.
Filter Example 3 In one embodiment, filter 515 includes variable coefficients such as, for example, coefficients that are a function of heart rate (or its conesponding time interval). In one example, operation of the filter 515 is described by Tn = a-w-AAn + (l-w)-r„_-, if AAn is concluded by an intrinsic beat, otherwise is described by Tn - b-wAAn + (l-w)-Tn_,, ifAAn is concluded by a paced beat, where at least one of a and b are linear, piecewise linear, or nonlinear functions of one or more previous A-A intervals such as, for example, the most recent A-A interval, AAn.
Figure 12 is a graph illustrating generally, by way of example, but not by way of limitation, one embodiment of using at least one of coefficients a and b as a function of one or more previous A-A intervals such as, for example, the most recent A-A interval, AAn. In one such example, a is less than 1.0 when AAn is at or near the lower rate limit (e.g., 1000 millisecond interval or 60 beats/minute), and a is greater than 1.0 when AAn is at or near the upper rate limit (e.g., 500 millisecond interval or 120 beats/minute). For a constant b, using a smaller value of a at lower rates will increase the pacing rate more quickly for sensed events; using a larger value of a at higher rates increases the pacing rate more slowly for sensed events. In another example, b is close to 1.0 when AAn is at or near the lower rate limit, and b is greater than 1.0 when AAn is at or near the upper rate limit. For a constant a, using a smaller value of b at lower rates will decrease the pacing rate more slowly for paced events; using a larger value of b at higher rates decreases pacing rate more quickly for paced events.
Conclusion The above-described system provides, among other things, a cardiac rhythm management system including an atrial pacing preference (APP) filter for promoting atrial pacing. The APP filter controls the timing of delivery of atrial pacing pulses. The atrial pacing pulses are delivered at a first indicated pacing rate, i.e., the APP-indicated rate, that is typically at a small amount above the intrinsic atrial heart rate. For sensed beats, the APP indicated pacing rate is increased until it becomes slightly faster than the intrinsic atrial heart rate. The APP-indicated pacing rate is then gradually decreased to search for the underlying intrinsic atrial heart rate. Then, after a sensed atrial beat, the APP filter again increases the APP indicated pacing rate until it becomes faster than the intrinsic atrial rate by a small amount. As a result, most atrial heart beats are paced, rather than sensed. This decreases the likelihood of the occunence of an atrial tachyanhythmia, such as atrial fibrillation. The decreased likelihood of atrial tachyanhythmia, in turn, decreases the likelihood of inducing a ventricular anhythmia, either as a result of the atrial tachyanhythmia, or as the result of delivering a defibrillation shock to treat the atrial tachyanhythmia. It is to be understood that the above description is intended to be illustrative, and not restrictive. Many other embodiments will be apparent to those of skill in the art upon reviewing the above description. The scope of the invention should, therefore, be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.

Claims

WHAT IS CLAIMED TS:
1. A system, comprising: an atrial sensing circuit for sensing atrial beats; a controller, obtaining A-A intervals between atrial beats and computing a first indicated pacing interval based at least on a most recent A-A interval duration and a previous value of the first indicated pacing interval; and an atrial therapy circuit, providing pacing therapy based on the first indicated pacing interval.
2. The system of claim 1, where the controller updates the first indicated interval (Tn) according to: Tn = A AAn + B -Tn_,, if AAn is concluded by an intrinsic beat, otherwise is updated according to Tn = CAAn + D -Tn_j, if AAn is concluded by a paced beat, where A, B, C and D are coefficients, and AAn is the A-A interval duration provided by the interval timer, and Tn . is the previous value of the first indicated interval.
3. The system of claim 2, in which A and B are different values.
4. The system of claim 2, in which C and D are different values.
5. The system of claims 3 and 4, in which C and A are different values.
6. The system of claim 2, in which at least one of A, B, C, and D is a function of rate.
7. The system of claim 1, in which the controller computes the first indicated pacing interval (Tn) according to: Tn = a-wAAn + (\-w)-Tn_„ ifAAn is concluded by an intrinsic beat, otherwise Tπ is computed according to Tn = b-w-AAn + (\-w)-Tn_,, if AAn is concluded by a paced beat, where b is a coefficient.
8. The system of claim 7, in which at least one of a, b, and v is a function of heart rate.
9. The system of claim 7, in which a and b are different values.
10. The system of claims 7-9, in which a is greater than a value selected from the group consisting of 0.5 and 1.0.
11. The system of claim 10, in which a is approximately equal to 1.1.
12. The system of claims 7- 11 , in which b is greater than a.
13. The system of claim 12, in which a is approximately equal to 1.1 and b is approximately equal to 1.2.
14. The system of claim 7, in which vv is approximately between 0 and 1.
15. The system of claim 1, further including a sensor, and in which the controller computes a second indicated pacing interval based on signals received from the sensor, and in which the atrial therapy circuit provides pacing therapy that is also based on the second indicated pacing interval.
16. The system of claim 1, further comprising a remote programmer, adapted for communication with the controller.
17. The system of claim 1, in which the controller adjusts the first indicated pacing interval, by differently weighting at least one of (1) the most recent A-A interval duration, or (2) the previous value of the first indicated pacing interval, if the most-recent A-A interval is concluded by a paced beat than if the most recent A-A interval is concluded by a sensed beat.
18. The system of claim 1, where the controller further includes a first register, for storing a first indicated pacing interval, and a filter, updating the first indicated pacing interval based on the A-A interval and the first register
19. The system of claim 18, in which the filter includes an infinite impulse response (IIR).
20. The system of claim 18, in which the filter includes a finite impulse response (FIR).
21. The system of claim 18, in which the filter includes an averager.
22. The system of claim 21, in which the filter includes a weighted averager.
23. A method, comprising: obtaining A-A intervals between atrial beats; computing a first indicated pacing interval based at least on a most recent A-A interval duration and a previous value of the first indicated pacing interval; and providing atrial pacing therapy, based on the first indicated pacing interval.
24. The method of claim 23, in which computing the first indicated pacing interval includes differently weighting at least one of (1) the most recent A-A interval duration, or (2) the previous value of the first indicated pacing interval, if the most-recent A-A interval is concluded by a paced beat than if the most recent A-A interval is concluded by a sensed beat.
25. The method of claim 23, in which computing the first indicated pacing interval includes summing a first addend based on the most recent A-A interval duration and a second addend based on the previous value of the first indicated pacing interval, wherein at least one of the first and second addends is different if the most recent A-A interval is concluded by an intrinsic beat than if the most recent A-A interval is concluded by a paced beat.
26. The method of claim 1, in which computing the first indicated pacing interval (Tn) is carried out according to Tn = A-AAn + B -Tn_j, where A and B are coefficients, AAn is the most recent A-A interval duration, and Tn_, is the previous value of the first indicated pacing interval.
27. The method of claim 26, in which computing the first indicated pacing interval (Tn) is carried out according to: Tn = A AAn + B -Tn_,, if ' AAn is concluded by an intrinsic beat, otherwise is carried out according to Tn = C An + D 'Tn_,, if AAn is concluded by a paced beat, where C and D are coefficients.
28. The method of claim 23, in which computing the first indicated pacing interval (Tn) is carried out according to Tn = a-w-AAn + (\-w)-Tn_j, where a and vv are coefficients, AAn is the most recent A-A interval duration, and Tn_, is the previous value of the first indicated pacing interval.
29. The method of claim 28, in which computing the first indicated pacing interval (Tn) is carried out according to: Tn = a-w-AAn + (\-w)-Tn_„ if AAn is concluded by an intrinsic beat, otherwise is carried out according to Tn = b w AAn +
Figure imgf000028_0001
is concluded by a paced beat, where b is a coefficient.
30. The method of claim 23, in which computing the first indicated pacing interval includes limiting the minimum first indicated pacing interval to be longer than or equal to an interval conesponding to an upper rate limit.
31. The method of claim 23, in which computing the first indicated pacing interval includes limiting the maximum first indicated pacing interval to be shorter than or equal to an interval conesponding to a lower rate limit.
PCT/US2000/013863 1999-05-21 2000-05-19 System promoting atrial pacing WO2000071201A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US09/316,682 US6351669B1 (en) 1999-05-21 1999-05-21 Cardiac rhythm management system promoting atrial pacing
AU51469/00A AU5146900A (en) 1999-05-21 2000-05-19 System promoting atrial pacing
PCT/US2000/013863 WO2000071201A1 (en) 1999-05-21 2000-05-19 System promoting atrial pacing
US09/693,402 US6353759B1 (en) 1999-05-21 2000-10-20 Cardiac rhythm management system promoting a trial pacing

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US09/316,515 US7062325B1 (en) 1999-05-21 1999-05-21 Method and apparatus for treating irregular ventricular contractions such as during atrial arrhythmia
US09/316,741 US6430438B1 (en) 1999-05-21 1999-05-21 Cardiac rhythm management system with atrial shock timing optimization
US09/316,515 1999-05-21
US09/316,588 US6285907B1 (en) 1999-05-21 1999-05-21 System providing ventricular pacing and biventricular coordination
US09/316,741 1999-05-21
US09/316,682 US6351669B1 (en) 1999-05-21 1999-05-21 Cardiac rhythm management system promoting atrial pacing
US09/316,588 1999-05-21
US09/316,682 1999-05-21
PCT/US2000/013863 WO2000071201A1 (en) 1999-05-21 2000-05-19 System promoting atrial pacing

Publications (1)

Publication Number Publication Date
WO2000071201A1 true WO2000071201A1 (en) 2000-11-30

Family

ID=36581730

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/013863 WO2000071201A1 (en) 1999-05-21 2000-05-19 System promoting atrial pacing

Country Status (3)

Country Link
US (2) US6351669B1 (en)
AU (1) AU5146900A (en)
WO (1) WO2000071201A1 (en)

Families Citing this family (150)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6266554B1 (en) 1999-02-12 2001-07-24 Cardiac Pacemakers, Inc. System and method for classifying cardiac complexes
US6223078B1 (en) 1999-03-12 2001-04-24 Cardiac Pacemakers, Inc. Discrimination of supraventricular tachycardia and ventricular tachycardia events
US6312388B1 (en) 1999-03-12 2001-11-06 Cardiac Pacemakers, Inc. Method and system for verifying the integrity of normal sinus rhythm templates
US8064997B2 (en) * 1999-05-21 2011-11-22 Cardiac Pacemakers, Inc. Method and apparatus for treating irregular ventricular contractions such as during atrial arrhythmia
US6501988B2 (en) * 2000-12-26 2002-12-31 Cardiac Pacemakers Inc. Apparatus and method for ventricular rate regularization with biventricular sensing
US7181278B2 (en) * 1999-05-21 2007-02-20 Cardiac Pacemakers, Inc. Apparatus and method for ventricular rate regularization
US7062325B1 (en) * 1999-05-21 2006-06-13 Cardiac Pacemakers Inc Method and apparatus for treating irregular ventricular contractions such as during atrial arrhythmia
US7212860B2 (en) * 1999-05-21 2007-05-01 Cardiac Pacemakers, Inc. Apparatus and method for pacing mode switching during atrial tachyarrhythmias
US7039461B1 (en) * 2000-05-13 2006-05-02 Cardiac Pacemakers, Inc. Cardiac pacing system for prevention of ventricular fibrillation and ventricular tachycardia episode
US6522925B1 (en) * 2000-05-13 2003-02-18 Cardiac Pacemakers, Inc. System and method for detection enhancement programming
US7239914B2 (en) * 2000-05-13 2007-07-03 Cardiac Pacemakers, Inc. Rate smoothing control
US6501987B1 (en) * 2000-05-26 2002-12-31 Cardiac Pacemakers, Inc. Rate smoothing control
US8512220B2 (en) * 2000-05-26 2013-08-20 Cardiac Pacemakers, Inc. Rate smoothing control
US6424865B1 (en) 2000-07-13 2002-07-23 Cardiac Pacemakers, Inc. Ventricular conduction delay trending system and method
US6829504B1 (en) * 2000-09-14 2004-12-07 Cardiac Pacemakers, Inc. System and method for preventing recurrence of atrial tachyarrhythmia
US6978177B1 (en) 2000-11-14 2005-12-20 Cardiac Pacemakers, Inc. Method and apparatus for using atrial discrimination algorithms to determine optimal pacing therapy and therapy timing
US6957100B2 (en) * 2000-12-26 2005-10-18 Cardiac Pacemakers, Inc. Method and system for display of cardiac event intervals in a resynchronization pacemaker
US20020087198A1 (en) * 2000-12-29 2002-07-04 Kramer Andrew P. Apparatus and method for ventricular rate regularization
US20050080348A1 (en) * 2003-09-18 2005-04-14 Stahmann Jeffrey E. Medical event logbook system and method
US7079891B1 (en) 2003-02-25 2006-07-18 Pacesetter System and method for providing cardioversion therapy and overdrive pacing using an implantable cardiac stimulation device
US7113822B1 (en) 2003-02-25 2006-09-26 Pacesetter, Inc. System and method for providing cardioversion therapy and overdrive pacing using an implantable cardiac stimulation device
US7499750B2 (en) * 2003-04-11 2009-03-03 Cardiac Pacemakers, Inc. Noise canceling cardiac electrodes
US8192358B2 (en) * 2003-04-22 2012-06-05 Patrick Leahy Device and method for use in surgery
US7477932B2 (en) * 2003-05-28 2009-01-13 Cardiac Pacemakers, Inc. Cardiac waveform template creation, maintenance and use
US7510531B2 (en) * 2003-09-18 2009-03-31 Cardiac Pacemakers, Inc. System and method for discrimination of central and obstructive disordered breathing events
EP1670547B1 (en) * 2003-08-18 2008-11-12 Cardiac Pacemakers, Inc. Patient monitoring system
US20050142070A1 (en) * 2003-09-18 2005-06-30 Hartley Jesse W. Methods and systems for assessing pulmonary disease with drug therapy control
US7468040B2 (en) * 2003-09-18 2008-12-23 Cardiac Pacemakers, Inc. Methods and systems for implantably monitoring external breathing therapy
US7610094B2 (en) * 2003-09-18 2009-10-27 Cardiac Pacemakers, Inc. Synergistic use of medical devices for detecting medical disorders
US7757690B2 (en) 2003-09-18 2010-07-20 Cardiac Pacemakers, Inc. System and method for moderating a therapy delivered during sleep using physiologic data acquired during non-sleep
US7887493B2 (en) * 2003-09-18 2011-02-15 Cardiac Pacemakers, Inc. Implantable device employing movement sensing for detecting sleep-related disorders
US7396333B2 (en) * 2003-08-18 2008-07-08 Cardiac Pacemakers, Inc. Prediction of disordered breathing
US8192376B2 (en) 2003-08-18 2012-06-05 Cardiac Pacemakers, Inc. Sleep state classification
US7575553B2 (en) * 2003-09-18 2009-08-18 Cardiac Pacemakers, Inc. Methods and systems for assessing pulmonary disease
US7336996B2 (en) * 2003-09-18 2008-02-26 Cardiac Pacemakers, Inc. Rate regularization of cardiac pacing for disordered breathing therapy
US7680537B2 (en) * 2003-08-18 2010-03-16 Cardiac Pacemakers, Inc. Therapy triggered by prediction of disordered breathing
US7591265B2 (en) 2003-09-18 2009-09-22 Cardiac Pacemakers, Inc. Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
US7572225B2 (en) * 2003-09-18 2009-08-11 Cardiac Pacemakers, Inc. Sleep logbook
US7720541B2 (en) * 2003-08-18 2010-05-18 Cardiac Pacemakers, Inc. Adaptive therapy for disordered breathing
US8606356B2 (en) * 2003-09-18 2013-12-10 Cardiac Pacemakers, Inc. Autonomic arousal detection system and method
US7668591B2 (en) 2003-09-18 2010-02-23 Cardiac Pacemakers, Inc. Automatic activation of medical processes
US7662101B2 (en) * 2003-09-18 2010-02-16 Cardiac Pacemakers, Inc. Therapy control based on cardiopulmonary status
US7678061B2 (en) * 2003-09-18 2010-03-16 Cardiac Pacemakers, Inc. System and method for characterizing patient respiration
US8251061B2 (en) * 2003-09-18 2012-08-28 Cardiac Pacemakers, Inc. Methods and systems for control of gas therapy
US7967756B2 (en) * 2003-09-18 2011-06-28 Cardiac Pacemakers, Inc. Respiratory therapy control based on cardiac cycle
US7364547B2 (en) * 2003-09-18 2008-04-29 Cardiac Pacemakers, Inc. Use of external respiratory therapy device to detect cardiac electrical activity
US7469697B2 (en) 2003-09-18 2008-12-30 Cardiac Pacemakers, Inc. Feedback system and method for sleep disordered breathing therapy
US7062328B1 (en) 2003-08-25 2006-06-13 Pacesetter, Inc. System and method for providing improved specificity for automatic mode switching within an implantable medical device
US20060247693A1 (en) 2005-04-28 2006-11-02 Yanting Dong Non-captured intrinsic discrimination in cardiac pacing response classification
US7319900B2 (en) * 2003-12-11 2008-01-15 Cardiac Pacemakers, Inc. Cardiac response classification using multiple classification windows
US8521284B2 (en) * 2003-12-12 2013-08-27 Cardiac Pacemakers, Inc. Cardiac response classification using multisite sensing and pacing
US7774064B2 (en) * 2003-12-12 2010-08-10 Cardiac Pacemakers, Inc. Cardiac response classification using retriggerable classification windows
US7515956B2 (en) * 2004-05-12 2009-04-07 Cardiac Pacemakers, Inc. Template based AV/VA interval comparison for the discrimination of cardiac arrhythmias
US7747323B2 (en) 2004-06-08 2010-06-29 Cardiac Pacemakers, Inc. Adaptive baroreflex stimulation therapy for disordered breathing
US8818504B2 (en) 2004-12-16 2014-08-26 Cardiac Pacemakers Inc Leadless cardiac stimulation device employing distributed logic
JP2006185060A (en) * 2004-12-27 2006-07-13 Fujitsu Ltd Method for inputting password
US7680534B2 (en) 2005-02-28 2010-03-16 Cardiac Pacemakers, Inc. Implantable cardiac device with dyspnea measurement
US7392086B2 (en) 2005-04-26 2008-06-24 Cardiac Pacemakers, Inc. Implantable cardiac device and method for reduced phrenic nerve stimulation
US7499751B2 (en) * 2005-04-28 2009-03-03 Cardiac Pacemakers, Inc. Cardiac signal template generation using waveform clustering
US8391990B2 (en) * 2005-05-18 2013-03-05 Cardiac Pacemakers, Inc. Modular antitachyarrhythmia therapy system
US20070055115A1 (en) * 2005-09-08 2007-03-08 Jonathan Kwok Characterization of sleep disorders using composite patient data
US20070118180A1 (en) 2005-11-18 2007-05-24 Quan Ni Cardiac resynchronization therapy for improved hemodynamics based on disordered breathing detection
US7697987B2 (en) * 2006-04-26 2010-04-13 Medtronic, Inc. Method and system for detecting cardiac arrhythmias during overdrive pacing
US8209013B2 (en) * 2006-09-14 2012-06-26 Cardiac Pacemakers, Inc. Therapeutic electrical stimulation that avoids undesirable activation
US20080183231A1 (en) * 2007-01-30 2008-07-31 Cardiac Pacemakers, Inc. Systems, devices and methods to alter autonomic tone
US20080228093A1 (en) * 2007-03-13 2008-09-18 Yanting Dong Systems and methods for enhancing cardiac signal features used in morphology discrimination
US9037239B2 (en) 2007-08-07 2015-05-19 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
US8265736B2 (en) 2007-08-07 2012-09-11 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
US20090149904A1 (en) * 2007-12-11 2009-06-11 Cardiac Pacemakers, Inc. Lv unipolar sensing or pacing vector
WO2009075725A1 (en) 2007-12-13 2009-06-18 Cardiac Pacemakers, Inc. Supraventricular tachy sensing vector
CN101939051B (en) 2008-02-14 2013-07-10 心脏起搏器公司 Method and apparatus for phrenic stimulation detection
ES2661718T3 (en) 2014-01-10 2018-04-03 Cardiac Pacemakers, Inc. Methods and systems to improve communication between medical devices
EP3092034B1 (en) 2014-01-10 2019-10-30 Cardiac Pacemakers, Inc. Systems for detecting cardiac arrhythmias
US9526909B2 (en) 2014-08-28 2016-12-27 Cardiac Pacemakers, Inc. Medical device with triggered blanking period
EP3253449B1 (en) 2015-02-06 2018-12-12 Cardiac Pacemakers, Inc. Systems for safe delivery of electrical stimulation therapy
EP3827877A1 (en) 2015-02-06 2021-06-02 Cardiac Pacemakers, Inc. Systems for treating cardiac arrhythmias
US10046167B2 (en) 2015-02-09 2018-08-14 Cardiac Pacemakers, Inc. Implantable medical device with radiopaque ID tag
WO2016141046A1 (en) 2015-03-04 2016-09-09 Cardiac Pacemakers, Inc. Systems and methods for treating cardiac arrhythmias
WO2016149262A1 (en) 2015-03-18 2016-09-22 Cardiac Pacemakers, Inc. Communications in a medical device system with link quality assessment
US10050700B2 (en) 2015-03-18 2018-08-14 Cardiac Pacemakers, Inc. Communications in a medical device system with temporal optimization
US10357159B2 (en) 2015-08-20 2019-07-23 Cardiac Pacemakers, Inc Systems and methods for communication between medical devices
CN108136186B (en) 2015-08-20 2021-09-17 心脏起搏器股份公司 System and method for communication between medical devices
US9968787B2 (en) 2015-08-27 2018-05-15 Cardiac Pacemakers, Inc. Spatial configuration of a motion sensor in an implantable medical device
US9956414B2 (en) 2015-08-27 2018-05-01 Cardiac Pacemakers, Inc. Temporal configuration of a motion sensor in an implantable medical device
US10137305B2 (en) 2015-08-28 2018-11-27 Cardiac Pacemakers, Inc. Systems and methods for behaviorally responsive signal detection and therapy delivery
US10226631B2 (en) 2015-08-28 2019-03-12 Cardiac Pacemakers, Inc. Systems and methods for infarct detection
US10159842B2 (en) 2015-08-28 2018-12-25 Cardiac Pacemakers, Inc. System and method for detecting tamponade
WO2017044389A1 (en) 2015-09-11 2017-03-16 Cardiac Pacemakers, Inc. Arrhythmia detection and confirmation
US10065041B2 (en) 2015-10-08 2018-09-04 Cardiac Pacemakers, Inc. Devices and methods for adjusting pacing rates in an implantable medical device
US10183170B2 (en) 2015-12-17 2019-01-22 Cardiac Pacemakers, Inc. Conducted communication in a medical device system
US10905886B2 (en) 2015-12-28 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device for deployment across the atrioventricular septum
WO2017127548A1 (en) 2016-01-19 2017-07-27 Cardiac Pacemakers, Inc. Devices for wirelessly recharging a rechargeable battery of an implantable medical device
US10350423B2 (en) 2016-02-04 2019-07-16 Cardiac Pacemakers, Inc. Delivery system with force sensor for leadless cardiac device
CN108883286B (en) 2016-03-31 2021-12-07 心脏起搏器股份公司 Implantable medical device with rechargeable battery
US10328272B2 (en) 2016-05-10 2019-06-25 Cardiac Pacemakers, Inc. Retrievability for implantable medical devices
US10668294B2 (en) 2016-05-10 2020-06-02 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker configured for over the wire delivery
CN109414582B (en) 2016-06-27 2022-10-28 心脏起搏器股份公司 Cardiac therapy system for resynchronization pacing management using subcutaneous sensing of P-waves
WO2018009569A1 (en) 2016-07-06 2018-01-11 Cardiac Pacemakers, Inc. Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system
US10426962B2 (en) 2016-07-07 2019-10-01 Cardiac Pacemakers, Inc. Leadless pacemaker using pressure measurements for pacing capture verification
US10688304B2 (en) 2016-07-20 2020-06-23 Cardiac Pacemakers, Inc. Method and system for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system
US10391319B2 (en) 2016-08-19 2019-08-27 Cardiac Pacemakers, Inc. Trans septal implantable medical device
US10780278B2 (en) 2016-08-24 2020-09-22 Cardiac Pacemakers, Inc. Integrated multi-device cardiac resynchronization therapy using P-wave to pace timing
US10870008B2 (en) 2016-08-24 2020-12-22 Cardiac Pacemakers, Inc. Cardiac resynchronization using fusion promotion for timing management
EP3515553B1 (en) 2016-09-21 2020-08-26 Cardiac Pacemakers, Inc. Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery
US10994145B2 (en) 2016-09-21 2021-05-04 Cardiac Pacemakers, Inc. Implantable cardiac monitor
US10758737B2 (en) 2016-09-21 2020-09-01 Cardiac Pacemakers, Inc. Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter
WO2018081275A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Multi-device cardiac resynchronization therapy with timing enhancements
US10561330B2 (en) 2016-10-27 2020-02-18 Cardiac Pacemakers, Inc. Implantable medical device having a sense channel with performance adjustment
US10413733B2 (en) 2016-10-27 2019-09-17 Cardiac Pacemakers, Inc. Implantable medical device with gyroscope
JP7038115B2 (en) 2016-10-27 2022-03-17 カーディアック ペースメイカーズ, インコーポレイテッド Implantable medical device with pressure sensor
WO2018081237A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Use of a separate device in managing the pace pulse energy of a cardiac pacemaker
US10758724B2 (en) 2016-10-27 2020-09-01 Cardiac Pacemakers, Inc. Implantable medical device delivery system with integrated sensor
CN109890456B (en) 2016-10-31 2023-06-13 心脏起搏器股份公司 System for activity level pacing
WO2018081721A1 (en) 2016-10-31 2018-05-03 Cardiac Pacemakers, Inc Systems for activity level pacing
WO2018089311A1 (en) 2016-11-08 2018-05-17 Cardiac Pacemakers, Inc Implantable medical device for atrial deployment
EP3538213B1 (en) 2016-11-09 2023-04-12 Cardiac Pacemakers, Inc. Systems and devices for setting cardiac pacing pulse parameters for a cardiac pacing device
WO2018093605A1 (en) 2016-11-21 2018-05-24 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker providing cardiac resynchronization therapy
CN109963618B (en) 2016-11-21 2023-07-04 心脏起搏器股份公司 Leadless cardiac pacemaker with multi-mode communication
US10881869B2 (en) 2016-11-21 2021-01-05 Cardiac Pacemakers, Inc. Wireless re-charge of an implantable medical device
US10639486B2 (en) 2016-11-21 2020-05-05 Cardiac Pacemakers, Inc. Implantable medical device with recharge coil
US11147979B2 (en) 2016-11-21 2021-10-19 Cardiac Pacemakers, Inc. Implantable medical device with a magnetically permeable housing and an inductive coil disposed about the housing
US11207532B2 (en) 2017-01-04 2021-12-28 Cardiac Pacemakers, Inc. Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system
EP3573706A1 (en) 2017-01-26 2019-12-04 Cardiac Pacemakers, Inc. Intra-body device communication with redundant message transmission
US10737102B2 (en) 2017-01-26 2020-08-11 Cardiac Pacemakers, Inc. Leadless implantable device with detachable fixation
WO2018140623A1 (en) 2017-01-26 2018-08-02 Cardiac Pacemakers, Inc. Leadless device with overmolded components
US10905872B2 (en) 2017-04-03 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device with a movable electrode biased toward an extended position
AU2018248361B2 (en) 2017-04-03 2020-08-27 Cardiac Pacemakers, Inc. Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate
WO2019036600A1 (en) 2017-08-18 2019-02-21 Cardiac Pacemakers, Inc. Implantable medical device with pressure sensor
US10918875B2 (en) 2017-08-18 2021-02-16 Cardiac Pacemakers, Inc. Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator
CN111107899B (en) 2017-09-20 2024-04-02 心脏起搏器股份公司 Implantable medical device with multiple modes of operation
US11185703B2 (en) 2017-11-07 2021-11-30 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker for bundle of his pacing
EP3717059A1 (en) 2017-12-01 2020-10-07 Cardiac Pacemakers, Inc. Methods and systems for detecting atrial contraction timing fiducials within a search window from a ventricularly implanted leadless cardiac pacemaker
EP3717060B1 (en) 2017-12-01 2022-10-05 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with reversionary behavior
CN111417433A (en) 2017-12-01 2020-07-14 心脏起搏器股份公司 Method and system for detecting atrial contraction timing reference during ventricular filling from a ventricular implanted leadless cardiac pacemaker
EP3717063B1 (en) 2017-12-01 2023-12-27 Cardiac Pacemakers, Inc. Systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker
CN111556773A (en) 2018-01-04 2020-08-18 心脏起搏器股份公司 Dual chamber pacing without beat-to-beat communication
US11529523B2 (en) 2018-01-04 2022-12-20 Cardiac Pacemakers, Inc. Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone
CN111936046A (en) 2018-03-23 2020-11-13 美敦力公司 VFA cardiac therapy for tachycardia
WO2019183512A1 (en) 2018-03-23 2019-09-26 Medtronic, Inc. Vfa cardiac resynchronization therapy
CN111886046A (en) 2018-03-23 2020-11-03 美敦力公司 AV-synchronized VFA cardiac therapy
EP3856331A1 (en) 2018-09-26 2021-08-04 Medtronic, Inc. Capture in ventricle-from-atrium cardiac therapy
US11951313B2 (en) 2018-11-17 2024-04-09 Medtronic, Inc. VFA delivery systems and methods
US11679265B2 (en) 2019-02-14 2023-06-20 Medtronic, Inc. Lead-in-lead systems and methods for cardiac therapy
US11697025B2 (en) 2019-03-29 2023-07-11 Medtronic, Inc. Cardiac conduction system capture
US11213676B2 (en) 2019-04-01 2022-01-04 Medtronic, Inc. Delivery systems for VfA cardiac therapy
US11712188B2 (en) 2019-05-07 2023-08-01 Medtronic, Inc. Posterior left bundle branch engagement
US11305127B2 (en) 2019-08-26 2022-04-19 Medtronic Inc. VfA delivery and implant region detection
US11813466B2 (en) 2020-01-27 2023-11-14 Medtronic, Inc. Atrioventricular nodal stimulation
US11911168B2 (en) 2020-04-03 2024-02-27 Medtronic, Inc. Cardiac conduction system therapy benefit determination
US11813464B2 (en) 2020-07-31 2023-11-14 Medtronic, Inc. Cardiac conduction system evaluation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011745A1 (en) * 1995-09-29 1997-04-03 Medtronic, Inc. Modification of pacemaker tachy response based on ffrw sensing

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4030510A (en) 1970-03-10 1977-06-21 General Electric Company Standby heart pacer
US3857399A (en) 1970-03-24 1974-12-31 F Zacouto Heart pacer
US4163451A (en) 1977-10-26 1979-08-07 Cordis Corporation Interactive method and digitally timed apparatus for cardiac pacing arrhythmia treatment
US4284082A (en) 1979-12-12 1981-08-18 Medtronic B.V.Kerkrade Ventricular synchronized atrial pacemaker and method of operation
US4556063A (en) 1980-10-07 1985-12-03 Medtronic, Inc. Telemetry system for a medical device
US4830006B1 (en) 1986-06-17 1997-10-28 Intermedics Inc Implantable cardiac stimulator for detection and treatment of ventricular arrhythmias
US4920965A (en) 1987-11-25 1990-05-01 Medtronic, Inc. Dual chamber pacemaker with adaptive atrial escape interval
US4917115A (en) 1988-07-11 1990-04-17 Vitatron Medical B. V. Pacing system and method for physiological stimulation of the heart utilizing Doppler means
US4928688A (en) 1989-01-23 1990-05-29 Mieczyslaw Mirowski Method and apparatus for treating hemodynamic disfunction
US4998974A (en) 1990-01-05 1991-03-12 Telectronics Pacing Systems, Inc. Apparatus and method for antitachycardia pacing in dual chamber arrhythmia control system
US5127404A (en) 1990-01-22 1992-07-07 Medtronic, Inc. Telemetry format for implanted medical device
US5085215A (en) 1990-03-20 1992-02-04 Telectronics Pacing Systems, Inc. Metabolic demand driven rate-responsive pacemaker
US5129394A (en) 1991-01-07 1992-07-14 Medtronic, Inc. Method and apparatus for controlling heart rate in proportion to left ventricular pressure
US5139020A (en) 1991-03-08 1992-08-18 Telectronics Pacing Systems, Inc. Method and apparatus for controlling the hemodynamic state of a patient based on systolic time interval measurements detecting using doppler ultrasound techniques
US5183040A (en) 1991-03-08 1993-02-02 Telectronics Pacing Systems, Inc. Apparatus and method for detecting abnormal cardiac rhythms using an ultrasound sensor in an arrhythmia control system
US5156154A (en) 1991-03-08 1992-10-20 Telectronics Pacing Systems, Inc. Monitoring the hemodynamic state of a patient from measurements of myocardial contractility using doppler ultrasound techniques
US5188106A (en) 1991-03-08 1993-02-23 Telectronics Pacing Systems, Inc. Method and apparatus for chronically monitoring the hemodynamic state of a patient using doppler ultrasound
JP2655204B2 (en) 1991-04-05 1997-09-17 メドトロニック インコーポレーテッド Implantable medical device
US5292339A (en) 1991-06-14 1994-03-08 Telectronics Pacing Systems, Inc. Implantable pacemaker/cardioverter/defibrillator device and method incorporating multiple bradycardia support pacing rates
US5284491A (en) 1992-02-27 1994-02-08 Medtronic, Inc. Cardiac pacemaker with hysteresis behavior
US5417714A (en) 1992-03-05 1995-05-23 Pacesetter, Inc. DDI pacing with PVC-protected hysteresis and automatic AV interval adjustment
SE9202825D0 (en) 1992-09-30 1992-09-30 Siemens Elema Ab HJAERTSTIMULATOR
US5282836A (en) 1992-10-23 1994-02-01 Incontrol, Inc. Atrial defibrillator and method for providing pre-cardioversion pacing
US5207219A (en) 1992-10-23 1993-05-04 Incontrol, Inc. Atrial defibrillator and method for providing interval timing prior to cardioversion
SE9203171D0 (en) 1992-10-28 1992-10-28 Siemens Elema Ab DEVICE FOR IDENTIFICATION OF ATRIAL DEPOLARIZATION
US5312452A (en) 1992-11-03 1994-05-17 Cardiac Pacemakers, Inc. Cardiac rhythm management device with automatic optimization of performance related pacing parameters
US5814077A (en) 1992-11-13 1998-09-29 Pacesetter, Inc. Pacemaker and method of operating same that provides functional atrial cardiac pacing with ventricular support
US5741308A (en) 1992-11-13 1998-04-21 Pacesetter, Inc. Dual-chamber implantable pacemaker and method of operating same for automatically setting the pacemaker's AV interval as a function of a natural measured conduction time
US5690689A (en) 1992-11-13 1997-11-25 Pacesetter, Inc. Dual-chamber implantable stimulation device having adaptive AV intervall and method for treating cardiomyopathy thereof
AU5205493A (en) 1992-12-01 1994-06-16 Siemens Aktiengesellschaft Cardiac event detection in implantable medical devices
US5383910A (en) 1993-02-19 1995-01-24 Medtronic, Inc. Method and apparatus for tachyarrhythmia detection and treatment
US5350409A (en) 1993-04-19 1994-09-27 Vitatron Medical, B.V. Rate adaptive pacemaker with adjustment of sensor rate as a function of sensed sinus rate
FR2705576B1 (en) 1993-05-28 1995-07-07 Ela Medical Sa A method of analyzing cardiac activity to determine whether a tachyarrhythmia is likely to be stopped by stimulation.
US5738096A (en) 1993-07-20 1998-04-14 Biosense, Inc. Cardiac electromechanics
US5365932A (en) 1993-09-02 1994-11-22 Telectronics Pacing System, Inc. Cardiac signal sensing device having sensitivity automatically controlled in response to metabolic demand
US5411531A (en) 1993-09-23 1995-05-02 Medtronic, Inc. Method and apparatus for control of A-V interval
US5522859A (en) 1993-09-29 1996-06-04 Medtronic, Inc. Sinus preference method and apparatus for cardiac pacemakers
US5411524A (en) 1993-11-02 1995-05-02 Medtronic, Inc. Method and apparatus for synchronization of atrial defibrillation pulses
US5391189A (en) * 1993-11-04 1995-02-21 Vitatron Medical, B.V. Rate adaptive dual chamber pacing system and method with automatic adjustment of operating parameters for minimizing sensor-sinus competition
US5507782A (en) 1994-03-17 1996-04-16 Medtronic, Inc. Method and apparatus for dual chamber cardiac pacing
FR2718035B1 (en) 1994-04-05 1996-08-30 Ela Medical Sa Method for controlling a double atrial pacemaker of the triple chamber type programmable in fallback mode.
US5584864A (en) 1994-06-14 1996-12-17 Incontrol, Inc. Cardioversion synchronization system and method for an atrial defibrillator
US5486198A (en) 1994-08-12 1996-01-23 Ayers; Gregory M. Atrial defibrillator and method for providing interval timing of successive intervals prior to cardioversion
SE9402865D0 (en) 1994-08-29 1994-08-29 Siemens Elema Ab Implantable cardiac defibrillator
US5540727A (en) 1994-11-15 1996-07-30 Cardiac Pacemakers, Inc. Method and apparatus to automatically optimize the pacing mode and pacing cycle parameters of a dual chamber pacemaker
US5487752A (en) 1994-11-15 1996-01-30 Cardiac Pacemakers, Inc. Automated programmable stimulating device to optimize pacing parameters and method
US5480413A (en) 1994-11-30 1996-01-02 Telectronics Pacing Systems, Inc. Apparatus and method for stabilizing the ventricular rate of a heart during atrial fibrillation
US5527347A (en) 1995-02-21 1996-06-18 Medtronic, Inc. Dual chamber pacing system and method with automatic adjustment of the AV escape interval for treating cardiomyopathy
US5514163A (en) 1995-02-21 1996-05-07 Medtronic, Inc. Dual chamber pacing system and method with optimized adjustment of the AV escape interval for treating cardiomyopathy
US5626620A (en) 1995-02-21 1997-05-06 Medtronic, Inc. Dual chamber pacing system and method with continual adjustment of the AV escape interval so as to maintain optimized ventricular pacing for treating cardiomyopathy
US5534016A (en) 1995-02-21 1996-07-09 Vitatron Medical, B.V. Dual chamber pacing system and method utilizing detection of ventricular fusion for adjustment of the atrial-ventricular delay as therapy for hypertrophic obstructive cardiomyopathy
US5545186A (en) 1995-03-30 1996-08-13 Medtronic, Inc. Prioritized rule based method and apparatus for diagnosis and treatment of arrhythmias
US5725561A (en) 1995-06-09 1998-03-10 Medtronic, Inc. Method and apparatus for variable rate cardiac stimulation
US5788717A (en) 1995-07-11 1998-08-04 Pacesetter, Inc. Atrial rate determination and atrial tachycardia detection in a dual-chamber implantable pacemaker
WO1997011746A1 (en) 1995-09-29 1997-04-03 Medtronic, Inc. Adaptive search av and auto pvarp adaptation to same with additional benefit
FR2739783B1 (en) 1995-10-13 1998-01-23 Ela Medical Sa DEFIBRILLATOR / ACTIVE IMPLANTABLE CARDIOVERVER MEDICAL DEVICE WITH HEADSET DEFIBRILLATION
US5836987A (en) 1995-11-15 1998-11-17 Cardiac Pacemakers, Inc. Apparatus and method for optimizing cardiac performance by determining the optimal timing interval from an accelerometer signal
US5674255A (en) 1995-12-14 1997-10-07 Cardiac Pacemakers, Inc. Dual chamber pacer having automatic PVARP
US5776167A (en) 1996-02-27 1998-07-07 Pacesetter, Inc. System and method for alleviating the effects of pacemaker crosstalk
US5716383A (en) 1996-02-28 1998-02-10 Medtronic, Inc. Dual chamber pacing system and method with continual adjustment of the AV escape interval so as to maintain optimized ventricular pacing for treating cardiomyopathy
US5626623A (en) 1996-04-30 1997-05-06 Medtronic, Inc. Method and apparatus for optimizing pacemaker AV delay
US5713929A (en) 1996-05-03 1998-02-03 Medtronic, Inc. Arrhythmia and fibrillation prevention pacemaker using ratchet up and decay modes of operation
DE69702845T2 (en) 1996-05-14 2000-12-21 Medtronic Inc DEVICE RELATING TO PRIORITY RULES FOR DIAGNOSIS AND TREATMENT OF HEART ARHYTHMIA
US5730141A (en) 1996-06-07 1998-03-24 Pacesetter, Inc. Tachyarrhythmia detection method
US5800464A (en) 1996-10-03 1998-09-01 Medtronic, Inc. System for providing hyperpolarization of cardiac to enhance cardiac function
US5713932A (en) 1996-10-28 1998-02-03 Medtronic, Inc. Method and apparatus for determining atrial lead disclocation and confirming diagnosis of atrial tachyarrhythimias
US5700283A (en) 1996-11-25 1997-12-23 Cardiac Pacemakers, Inc. Method and apparatus for pacing patients with severe congestive heart failure
US5778881A (en) 1996-12-04 1998-07-14 Medtronic, Inc. Method and apparatus for discriminating P and R waves
US5755737A (en) 1996-12-13 1998-05-26 Medtronic, Inc. Method and apparatus for diagnosis and treatment of arrhythmias
US5846263A (en) 1996-12-13 1998-12-08 Medtronic, Inc. Apparatus for diagnosis and treatment of arrhythmias
US5893882A (en) 1996-12-17 1999-04-13 Medtronic, Inc. Method and apparatus for diagnosis and treatment of arrhythmias
US5836975A (en) 1996-12-19 1998-11-17 Medtronic, Inc. Method and apparatus for diagnosis and treatment of arrhythmias
US5814085A (en) 1996-12-19 1998-09-29 Medtronic, Inc. Rate stabilization pacemaker
US5983138A (en) 1997-04-04 1999-11-09 Cardiac Pacemakers, Inc. Device and method for ventricular tracking and pacing
US5978707A (en) 1997-04-30 1999-11-02 Cardiac Pacemakers, Inc. Apparatus and method for treating ventricular tachyarrhythmias
US5987356A (en) 1997-06-05 1999-11-16 Medtronic, Inc. Method and apparatus for diagnosis and treatment of arrhythmias
US5999850A (en) 1997-07-21 1999-12-07 Pacesetter, Inc. Pacemaker with safe R-wave synchronization during countershock conversion of atrial fibrillation
US5873897A (en) 1997-09-19 1999-02-23 Sulzer Intermedics Inc. Method and apparatus for dual chambered tachyarrhythmia classification and therapy
US5800471A (en) 1997-10-20 1998-09-01 Cardiac Pacemakers, Inc. Method for optimizing cardiac performance by determining the optimal pacing mode-AV delay from a transient heart rate signal for use in CHF, brady, and tachy/brady therapy devices
US5897575A (en) 1997-10-24 1999-04-27 Pacesetter, Inc. Arrhythmia classification system with reliability indication that allows for low quality input signals in pacemakers
US5951592A (en) 1997-11-21 1999-09-14 Pacesetter, Inc. Apparatus and method for applying antitachycardia therapy based on ventricular stability
US5935081A (en) 1998-01-20 1999-08-10 Cardiac Pacemakers, Inc. Long term monitoring of acceleration signals for optimization of pacing therapy
US5978710A (en) 1998-01-23 1999-11-02 Sulzer Intermedics Inc. Implantable cardiac stimulator with safe noise mode
US5944744A (en) 1998-02-06 1999-08-31 Sulzer Intermedics Inc. Implantable cardiac stimulator with automatic electrogram profiling
US5928271A (en) 1998-02-25 1999-07-27 Medtronic, Inc. Atrial anti-arrhythmia pacemaker and method using high rate atrial and backup ventricular pacing
US6026320A (en) 1998-06-08 2000-02-15 Cardiac Pacemakers, Inc. Heart rate variability as an indicator of exercise capacity
US6081745A (en) 1998-08-17 2000-06-27 Medtronic, Inc. Method and apparatus for treatment of arrhythmias
US6044298A (en) 1998-10-13 2000-03-28 Cardiac Pacemakers, Inc. Optimization of pacing parameters based on measurement of integrated acoustic noise
US6049735A (en) 1999-03-01 2000-04-11 Cardiac Pacemakers Inc. Cardiac rhythm management device with detection and therapy for sudden syncopal events

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011745A1 (en) * 1995-09-29 1997-04-03 Medtronic, Inc. Modification of pacemaker tachy response based on ffrw sensing

Also Published As

Publication number Publication date
US6351669B1 (en) 2002-02-26
AU5146900A (en) 2000-12-12
US6353759B1 (en) 2002-03-05

Similar Documents

Publication Publication Date Title
US6351669B1 (en) Cardiac rhythm management system promoting atrial pacing
US6430438B1 (en) Cardiac rhythm management system with atrial shock timing optimization
US7062325B1 (en) Method and apparatus for treating irregular ventricular contractions such as during atrial arrhythmia
EP1185335B1 (en) System providing ventricular pacing and biventricular coordination
US8046061B2 (en) System and method for preventing recurrence of atrial tachyarrhythmia
US5697884A (en) Cardiac assist device having circadian muscle simulation
EP1436043B1 (en) Cardiac rhythm management system
US8064997B2 (en) Method and apparatus for treating irregular ventricular contractions such as during atrial arrhythmia
US6510342B1 (en) Methods and apparatus for preventing atrial arrhythmias by overdrive pacing multiple heart tissue sites using an implantable cardiac stimulation device
WO1999040968A1 (en) Diagnostic test protocol in an implantable medical device
EP1053044A1 (en) Implantable cardiac stimulator with electrogram profiling
JPH09103501A (en) Heart assisting system
US7457663B2 (en) Cardiac rhythm management system providing control of pacing features with a reduced number of variables

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP